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CHAPTER I 
THE ALKALINE RNase INHIBITOR. 
1.1. Introduction. 
One of the key processes in the cell is the synthesis of RNA 
and its role in the synthesis of protein. After translation the 
protein is released from the ribosomes on which it has been syn­
thesized and the ribosomes, which are released as well, can then 
become attached again to an m-RNA molecule. During the process of 
protein biosynthesis the messenger is probably susceptible to at­
tack by nucleases, but the exact number of ribonucleases present 
in the cell is still unknown. The most extensively investigated 
ribonucleases are those which have pH optima at 5.8 and 7.8 and 
which have been designated as acid and alkaline ribonucleases, 
respectively. This thesis presents a study of a protein which can 
interact with alkaline ribonuclease to form a complex, which then 
no longer shows alkaline ribonuclease activity when assayed in a 
system containing a suitable buffer and RNA as substrate. 
1.2. Regulation of protein synthesis. 
Within the last five years it has become possible to isolate 
animal messenger RNA and to translate it in heterologous systems. 
One of the messengers which has been translated succesfully is the 
messenger which codes for the ctA chain of the lens protein α-crys­
tal lin. Since aA chains can be produced in cell-free systems from 
rabbit reticulocytes (Berns 1972) and frog oocytes (Berns 1972), 
the requirement for tissue specific messenger recognition factors 
seems to be highly unlikely. Protein synthesis will, among others, be 
dependent on the actual m-RNA concentration.Regulation of this con­
centration is possible by influencing the synthesis and degradation 
1 
processes. As well as the regulation of protein synthesis by produc-
tion of new m-RNA molecules, the translation process can also be 
influenced directly. These two aspects will now be briefly discussed. 
1.2.1 Regulation of protein synthesis on the transcriptional level. 
Protein synthesis is probably regulated by the actual m-RNA con-
centration. It is possible that the regulation of m-RNA concentra-
tion in the cytoplasm may be triggered by processes in the nucleus. 
The rate of transcription of DNA and synthesis of m-RNA molecules 
may influence the m-RNA concentration in the cytoplasm but also 
the turnover of m-RNA precursors in the nucleus, or perhaps their 
transport to the cytoplasm, may be involved. However, no evidence 
to support these possibilities is available. 
1.2.2 Regulation of protein synthesis on the translational level. 
Regulation on this level is possible by a variety of factors e.g. 
initiation factors, initiator t-RNA and the energy supply. One of the 
elongation factors, transferase I, may also be a limiting factor in 
protein biosynthesis (Girgis and Nicolls 1972). A great number of 
components involved in protein biosynthesis are known currently, in-
cluding a factor which is essential for the release of the protein 
from the ribosomes. Another mode of regulation of protein synthesis 
is provided by controlling the rate of degradation of the m-RNA mole-
cules themselves and this will now be discussed. 
1.3. Factors possibly involved in RNA degradation. 
The cell contains a number of enzymes for the degradation of 
cellular RNA, each of which has a specific way of degrading RNA. 
It is beyond the scope of this thesis to review all RNA degrading 
enzymes and the reader is referred to the numerous reviews on the 
subject, e.g. Anfinsen (1961), Roth (1967), Griffaton (1968), 
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Barnard (1969) and Gribnau (1970). 
The processes involved in the degradation of RNA in the cell are 
still obscure and the complexity of this problem will presumably not 
allow a rapid elucidation of the various mechanisms possible. In fact 
the complexity of the problem is becoming greater because the num­
ber of known RNA depolymerizing enzymes is still growing. An exam­
ple of the increasing number of RNases is the renewed discussion re­
garding ribosomal RNase (Gavard and de Lamirande 1972, Willis and ι 
Starr 1972). In rat liver an alkaline RNase associated with ribosomes 
was reported by Tashiro (1958, 1959, 1960) and Roth (1960), but 
Siekevitz and Palade (1960, 1962, 1963) demonstrated that this RNase 
activity was the result of adsorption of alkaline RNase from the 
supernatant by the acidic ribosomes. The adsorption was dependent 
on the concentration of added RNase, ionic strength and pH. The 
conditions used in the normal procedure for the isolation of ribo­
somes favour this adsorption process. However, Gavard and de Lami­
rande (1972) Ingebretsen et al. (1972) and Willis and Starr (1972) 
reported the occurrence of a ribosomal bound RNase, different in 
behaviour from alkaline RNase. The new ribosomal RNase differs from 
the alkaline RNase in its action on poly C, as well as in other 
respects. Another new RNase associated specifically with membrane 
bound polysomes was reported by Krechetova et al. (1972), who claim­
ed to have detected 5' RNase activity. This type of RNase, which re­
leases 5' phosphate nucleotidesand also degrades the purine-purine 
linkage of polyadenylic acid, has also been found in endoplasmic 
membranes by de Lamirande et al. (1966). This RNase may be impor­
tant, because m-RNA in Ε-coli apparently is degraded predominantly 
in the 5' to 3' direction in vivo (Kuwano et al.1970). Most RNases, 
however, release products ending in 3' phosphate and only a few 
RNases producing 5' phosphate nucleotides are known. In the E-coli 
system a ribosomal bound RNase has been described, which degrades 
m-RNA in the 5' to 3' direction; in addition to the substrate (m-RNA) 
this RNase also requires all the components needed for translocation 
2+ 
of ribosomes, i.e. ribosomes, t-RNA, G and Τ factors, GTP, Mg , 
NH. and glutathione (Kuwano et al.1969,1970).At the same time an RNase 
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degrading m-RNA from the 5' to 3' end was reported by Morikawa and 
Imamoto (1969) and Morse et al. (1969). Other factors besides 
RNases or phosphodiesterases, whose function presumably may be 
to split the smaller RNA fragments obtained after the action of 
RNase, can also play an important role in RNA degradation as will 
be demonstrated. 
1.3.1 Presence of specific RNase inhibitors. 
An alkaline RNase inhibitor is present in many organs and 
organisms. The distribution of this alkaline RNase inhibitor, first 
demonstrated in guinea pig liver (Pirotte and Desreux 1952) seems 
to be universal in mammals (Kraft 1970a) but is probably not pre-
sent in plants or microorganisms. 
1.3.2 Structure of RNA and the protection of RNA by proteins. 
In general, ordered configurations are less susceptible to RNase 
than randomly coiled structures. Protection of RNA by proteins is 
also possible. Ribosomal proteins associated with r-RNA in the ribo-
somes, or proteins associated with m-RNA, will prevent ribonuclease 
attack (Neu and Heppel 1964). Although the ribosomal proteins as-
sociated with r-RNA's in ribosomes do allow nuclease attack on 
that part of the ribosome which is not protected , the same proteins 
prevent subsequent disintegration of the ribosome. 
1.3.3 Compartmentalization of enzymes and substrates. 
An important aspect and a possible control mechanism for 
m-RNA catabolism may be the intracellular localization of the RNA 
degrading enzymes involved. An extensive study of intracellular 
localization has been made by Rahman (1966, 1967a, 1967b, 1969a, 
1969b). But the results of Rahman and the results of many other 
investigators on the distribution of intracellular RNase, have to 
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be interpreted very cautiously, since there is a considerable risk 
of contamination during the isolation of the discrete cell particles. 
The total disruption and destruction of cell organelles can lead 
to a redistribution of RNase. An example, given by Rahman (1967a), 
demonstrates the distribution of alkaline RNase in the rat liver 
(table I). 
Table I: Distribution of alkaline RNase in rat liver cells (from 
Rahman 1967a). 
cell fraction % of alkaline RNasex % of alkaline RNase after 
XX 
further purification 
2-3 
27 
20 
the activity is expressed in % of the activity of the unfractio-
nucleus 
mitochondria 
lysosomes 
microsomes 
supernatant 
14.5 
30.7 
11.8 
26.1 
24.0 
nated homogenate. 
the cell fractior 
with 0.25 M sucrose, water or Triton X-100. 
XX 
the cell fractions were further purified by extensive washings 
The remaining alkaline RNase activity in the nucleus may be a 
residual cytoplasmic contamination.Alkaline ribonuclease activity 
in the purified mitochondrial and microsomal fractions is probably 
not due to contamination and shows that at least some RNA degra-
ding enzymes are compartmentalized within cellular structures. 
Also the localization of acid RNase in lysosomes (Rahman 1967b) 
supports the idea of localization of enzymes in different cell 
particles. 
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1.4. Possible role of the RNase inhibitor in the cell. 
How difficult it is to find a correlation between RNA levels, 
RNase concentrations and protein synthetic activity in the cell, 
if indeed there is a correlation, was demonstrated by von Tiger-
strom (1972). Studying changes in RNA degrading enzymes in Ehrlich 
ascites cells he found that cells with low RNase activity and cells 
with high RNase activity, obtained by treating the Ehrlich ascites 
cells with actinomycin D before inoculation into mice, have the 
same rate of protein synthesis. 
This example underlines the point that possible relationships be-
tween RNA and alkaline RNase concentrations and the protein syn-
thetic activity must be interpreted with great care. 
Also the results concerning the role of the RNase inhibitor in 
neoplasmic tissue are not clear-cut and will therefore not be 
discussed ( Daoust 1963, Roth 1963,1964 and 1967). On the other 
hand in normal tissue there seems to be a relationship. This will 
be discussed in the following paragraphs. 
1.4.1 Protecting function of the RNase inhibitor. 
The presence of an RNase inhibitor in reticulocytes was repor-
ted by Priess and Zillig (1967) and Traub et al.(1966). Because 
in these cells no new RNA is synthesized, the function of the inhi-
bitor is probably a protecting one. 
It is well known that serum contains considerable amounts of RNase 
(Tsukada 1969), so the function of the inhibitor could be to bind 
alkaline RNase penetrating from the serum into the reticulocytes. 
Rosenthal et al.(1964, 1967) reported a ribosomal bound RNase, iso-
lated from rabbit reticulocytes, with an optimal activity at pH 7.5; 
therefore another possible function of the inhibitor in reticulo-
cytes may be association with that RNase to prevent RNA degradation. 
As well as the RNase inhibitor, haemin can also displayan RNase in-
hibiting function in reticulocytes. 
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1.4.2 Regulating function of the RNase inhibitor. 
The stabilizing effect of the inhibitor on polysomes in vitro 
is well established by the work of Bont et al.(1965) and Blobel 
and Potter (1966). These authors proved that the RNase inhibitor 
prevents the breakdown of isolated polysomes in vitro. The stabili-
zing effect of the inhibitor on the structure of polysomes has also 
been reported by others, e.g. Lawford (1967) and Gribnau (1969) 
who all found protection of the integrity of polysomes. 
The question as to whether or not high inhibitor levels in vitro 
result in more and larger polysomes, and a higher rate of protein 
production will be discussed later. 
Theoretically, high inhibitor levels, or perhaps it is better 
to say high inhibitor/RNase ratios,can lead to higher RNA levels 
because RNA synthesis continues while degradation is diminished. 
It would follow from this that high m-RNA levels could result 
in a more frequent translation and in a higher output of protein. 
The opposite might be true in cells with low inhibitor levels 
or rather in cells with a low inhibitor/RNA ratio. If the inhi-
bitor has a regulator function it should be possible to find a 
correlation between inhibitor level and the metabolic state of 
the tissue. This correlation has been looked for by several 
authors. 
Organs with high mitotic activity or a high rate of protein 
synthesis such as the thymus, liver and spleen have high RNase 
inhibitor levels , this in contrast to heart or brain tissues 
which have low inhibitor levels (Kraft 1970a). Suzuki (1970) 
made attempts to find in brain a correlation between areas with 
high RNA polymerase and protein synthesizing activity and high 
RNase inhibitor activity, but his results are too poor to prove 
such a correlation. 
Relatively high inhibitor levels are found in young animals.Kraft 
(1970a) found great differences 1n RNase inhibitor levels in rats 
of different ages,for example in rat thymus only 35% of the inhibi-
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tor activity was retained in 52 week old animals compared with the 
inhibitor activity in 9 week old rats. 
Suzuki (1970) demonstrated a reduction in inhibitor level in rat 
cerebral cortex on aging; within 13 days after birth the lower, 
adult, level was reached. 
An aging effect was also reported by Sarkar (1970, 1971); chicken 
embryos (4 days before hatching) contain detectable levels of RNase 
inhibitor which are absent in livers of hatched chicks. The age effect 
could be correlated with the amino acid incorporating activity of 
isolated polysomes (Sarkar 1970). 
Kraft and Shortman (1970b) have suggested a control function for 
the RNase inhibitor system based on studies of isolated cells and 
phytohaemagglutinin transformed lymphocytes. Lymphocytes from human 
peripheral blood have low cytoplasmic RNA levels and are relatively 
inactive in RNA and protein synthesis (Cooper 1965, 1966). The ribo-
nuclease inhibitor was not detected in these cells and alkaline ri-
bonuclease was present in a free state. When the lymphocytes were 
stimulated by phytohaemagglutinin to transform into blast-like cells 
with high synthetic activity these transformed cells developed high 
levels of inhibitor activity. Greif and Eich (1972) found an increase 
in thyroidal inhibitor concentration after stimulating the thyroid 
function of the rat with thiouracil, low iodine diet or thyroid sti-
mulating hormone administration to hypophysectomized rats. 
Another example of increased inhibitor levels in proportion to the 
RNA content was given by Rosso (1973). Unilateral nephrectomy in 
rats produced an increase in ribonuclease activity in cytoplasmic 
fractions of the contralateral kidney.A higher amount of inhibitor, 
determined by the difference between free and complexed RNase, was 
found before the RNA/DNA ratio increased. During compensatory renal 
growth the inhibitor level was raised as compared with the normal 
renal levels. 
Administration of phenobarbitone by 6 or 8 daily injections of 100 
mg/kg body weight causes a 60-80% reduction in RNase activity in 
hepatic postmicrosomal supernatant fractions. In vitro treatment of 
ribonuclease with phenobarbitone has no effect on RNase; this indi-
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cates that phenobarbitone has no effect on RNase level by direct 
action on the RNase molecule. The effect of the drug can be explain-
ed by induction of the RNase inhibitor (Stolman and Loh 1970). 
An increase in the inhibitor activity is found in regenerating rat 
liver as compared with sham-operated controls. Forty-eight h after 
partial hepatectomy the increase is 42%. The increased anabolic 
state of the tissue is in good agreement with the higher inhibitor 
levels (Shortman 1962). The results of Shortman were confirmed by 
Moriyama et al.(1969), who also found higher inhibitor levels in 
hepatectomized rats. An increased inhibitor level was found in 
rat adrenals after administration of ACTH (Imrie and Hutchinson 
1965). The inhibitor level was raised to 183% of the normal value 
18 h after ACTH administration. Administration of ACTH also increas-
ed the amount of RNA in rat adrenals (Imrie 1965) and this increase 
could be the result of an increase in inhibitor level. 
All these examples show that there is an increase in inhibitor level 
when there is an enhanced anabolic activity. The inverse trend (lo-
wer inhibitor levels correlated with catabolic activity) will be 
considered now. 
When male rats were treated with a single (large) dose of 25 mg of 
9-a-fluoroprednisolone/kg body weight, the ribonuclease activity in 
the thymus increased. This increase is the result of inactivation 
of the alkaline RNase inhibitor and this inactivation of the inhibi-
tor is accompanied by a 29% decrease in thymus RNA concentration 
(Wiernik and Macheod 1965). 
Treatment of human amnion cultures with proliferation inhibiting 
concentrations of cycloheximide (5.10" M) or the alkylating agent 
Trenimon (5.10" M) leads to disappearence of the ribonuclease in-
hibitor within one cell generation time. Trenimon induces an in-
crease (257%) in alkaline ribonuclease activity but cycloheximide 
treatment resultsin a decrease of 25% of the control value. A cor-
relation was suggested between the disappearence of the ribonuclease 
inhibitor and the proliferation arrest. 
Girya et al.(1965) reported a correlation between lowered protein 
synthetic activity and lower RNase inhibitor concentration in livers 
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of rats maintained on a protein free diet for 3 weeks. The results 
may be influenced by the lowering of the glycogen levels of the 
liver; a stabilizing effect of glycogen on the inhibitor activity 
has been reported by Sirakov and Schulga (1971). 
A 50% lowered RNase inhibitor level was observed in pigeon pan-
creas after starvation (Morisset et al. 1972). 
Radiation induced changes in the activities of alkaline ribonu-
clease and its inhibitor in rat thymus supernatant have also 
been reported (Patii et al. 1972). 
The depressed rates of protein synthesis observed after whole 
body X-irradiation may be the result of destroying the inhibitor. 
Perhaps this inactivation of the inhibitor takes place by the 
oxidation of SH groups. Such an oxidation was suggested by Kraft 
et al. (1969), who reported a decrease in inhibitor level in mouse 
thymus following X-radiation; the inactivation could be preven-
ted by intraperitoneal injections of 2-mercaptoethylamine 5 min 
before irradiation. 
Little and Meyer (1971) demonstrated that skeletal muscle extracts 
from mice with muscular dystrophy contained no detectable levels 
of RNase inhibitor. The disappearence of the inhibitor was accom-
panied by an increase in the alkaline RNase activity. The abnormal 
pattern was only seen in the skeletal muscle and the inhibitor 
levels in heart and liver were the same in normal and dystrophic 
mice. 
Similar results were obtained in the eye lens; in the normal eye 
lens of horses, cows and humans no measurable ribonuclease activity 
could be detected (Maione et al. 1968) but an increased ribonucle-
ase activity was demonstrated in lenses with a xylose or galactose 
cataract. The RNase activity was also increased in initial corti-
cal opacities involving not more than about one-half of the cortex, 
and similar results were also found in the case of senile cataract. 
The presence ofan RNase inhibitor in the bovine eye was clearly 
demonstrated by Ortwerth and Byrnes (1971,1972) who showed that the 
increased RNase activity was not the result of an increased amount 
of RNase but was due to a decreased RNase inhibitor level. 
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Although normal eye lenses contain both alkaline RNase and RNase 
inhibitor, the inhibitor is present in much greater amounts. 
As already mentioned, the concentration of free inhibitor is low 
in heart and brain, tissues with a relatively low rate of protein 
synthesis and cell division. Old tissues also have lower inhibitor 
levels (Kraft and Shortman 1970a); this result, however, could not 
be confirmed by Sarkar (1969) who found a slow increase in inhibitor 
level in the supernatant fraction of rat liver when studying rats 
ranging from one day to one year in age. Great changes were found by 
Sarkar in chick liver. He found high levels of alkaline RNase inhibi­
tor active against pancreatic ribonuclease in the chick embryo liver 
two and four days before hatching. The inhibitor activity disappeared 
completely following hatching. 
Cells with low anabolic or high catabolic activity also shows raised 
RNase levels instead of lower inhibitor activity. Grace and O'Dell 
(1970) reported an enhancement of alkaline RNase activity in liver 
homogenates from guinea pigs fed on Mg-deficient diets. These ani­
mals contained significantly higher concentrations of both alkaline 
and acid RNase activity. 
All these studies point to a possible relationship between the alka­
line RNase inhibitor level and the metabolic state of the tissue. 
1.5. Applications of the inhibitor. 
Apart from the theoretical significance of the possible function 
of the inhibitor in the cell its characteristic property of inhibi­
ting alkaline RNase with a pH optimum at 7.8, is very useful for 
experimental purposes. In particular, addition of the inhibitor, 
even in the most crude form such as the supernatant fraction from 
liver homogenates, considerably improves the yield and integrity 
of polyribosomes (Bont et al. 1965 and Spohr et al. 1972). Gribnau 
et al.(1969) obtained apparently undegraded profiles by incubating 
polyribosomes for 30 min. at 0° С, but at 37° С for 30 min. it was 
necessary to add inhibitor (partially purified) to the suspension in 
order to preserve the polysomal profile. Omitting the inhibitor from 
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incubations at 37° С gives a decreased amount of the heavier poly­
somes and increased amounts of monoribosomes. The inhibitor is also 
useful in the preparation of viral RNA or virus specific messenger 
RNA associated with polysomes (Gielkens et al. 1974). It is also 
helpful in all experiments(Burghouts et al. 1970) which require the 
presence of undegraded RNA. Caution is necessary because up to now 
only impure preparations have been available. Berns et al.(1971) 
reported a proteolytic activity in partly (DEAE-Sephadex) purified 
inhibitor preparations from rat liver. The proteolytic activity, 
which consisted at least partially of a potent leucine aminopep-
tidase, could be removed by gel filtration on Sephadex G-100. 
These results have to be kept in mind when studying protein syn­
thesis in cell free systems by using crude rat liver inhibitor 
to prevent RNA degradation. 
1.6. The occurrence of the inhibitor. 
Since the discovery of the RNase inhibitor by Pi rotte and 
Desreux (1952) in guinea pig liver supernatant, many organisms 
and organs have been tested for the presence of a similar inhibitor. 
1.6.1 The presence of the inhibitor in plants. 
Bernheimer and Steele (1955) examined 48 extracts of 41 dif­
ferent plants. Only the leaves of the lilac (Syringa vulgaris) seem 
to contain an inhibitor of pancreatic RNase and an apparently similar 
substance is also present in privet (Ligustrum vulgaris)leaves. 
The inhibitor in plant leaves is essentially different from the rat 
liver inhibitor as described by Roth (1956) in that it is probably 
not a protein. 
1.6.2 The presence of the inhibitor in prokaryotes. 
Descriptions of RNase inhibitors in bacteria are scarse. Short-
man was not able to detect an alkaline RNase inhibitor in Escheria 
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Coli) (Kraft and Shortman 1970a). Similar negative results were ob-
tained by Smeaton and Elliott (1967), who tested sonicated extracts 
of Staphylococcus aureus, Lactobacillus leichmanii. Streptococcus 
faecal i s and two, non RNase secreting, strains of Bacillus subtilis. 
In all cases no inhibitor activity could be detected. An exception 
was an RNase secreting strain of Bacillus subtilis; the inhibitor 
present in this strain is a specific inhibitor of bacterial RNase 
and possesses no inhibitor activity against pancreatic RNase. It 
also differs in other properties from the RNase inhibitor from rat 
liver. The former inhibitor is a protein, with a molecular weight 
of 12,500 daltons and in the RNase inhibitor complex the RNase acti-
vity cannot be restored by heating or by the addition of sulphydryl 
reagents. The inhibitor from Bacillus subtilis also differs in sta-
bility from the inhibitor of mammalian origin. Besides, the bacte-
rial inhibitor is only detectable at the end of the growth phase. 
when an extracellular ribonuclease is also produced by cultures 
of Bacillus subtilis. 
Recently the presence of an inhibitor in mycelial extracts of 
Neurosphora Crassa has been suggested (Argyrakis and Vomvoyanni 
1973). A time-dependent increase in RNase activity was found which 
is probably due to inactivation of a ribonuclease inhibitor, but 
regarding its nature and specificity nothing is known. In conclus-
ion we may assume that also in prokaryotes the alkaline RNase in-
hibitor is not present. 
1.6.3 The presence of the RNase inhibitor in higher organisms. 
A rather poor phylogenetic study was carried out by Kraft and 
Shortman (1970a). They proved that the liver of a marsupial possum 
and the liver of a monotreme (echidna), one of the lowest classes 
of mammalia, possess an inhibitor active against bovine pancreatic 
ribonuclease. 
The distribution of the inhibitor in higher organisms is listed in 
table II. 
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Table II: Alkaline RNase inhibitor in eukaryotes. 
Organism Organ Short Specification Reference 
Bovine 
Bovine 
Chick 
Dog 
Liver 
Reticulocytes 
Liver 
Thyroid 
Echidna Liver 
Guinea pig Liver 
Guinea pig 
Horse 
Man 
Man 
Man 
Man 
Mouse 
Seminal 
vesicles 
Reticulocytes 
Amnion cells 
Erythrocytes 
Red blood cells 
Thyroid 
Liver 
Inhibitor activity decreased to undetectable 
levels after hatching 
Low iodine diet resulted in enhanced RNase in-
hibitor levels 
Increase in RNase activity on H-SO» treatment 
After treatment with cycloheximide all inhi-
bitor activity disappeared within 24 h 
Buri 
Rost 
Sarkar 
Murthy 
Kraft 
Pi rotte 
Sirakov 
Sirakov 
Rost 
Hilz 
Kraft 
Gupta 
Greif 
Kraft 
(1970) 
(1952) 
(1969) 
(1970) 
(1959) 
(1968) 
(1970) 
(1963) 
(1972) 
(1970) 
1971) 
1959) 
1971) 
1974) 
Table II: Alkaline RNase inhibitor in eukaryotes (continued). 
Organism Organ Short S pecification Reference 
Mouse Skeletal muscle 
Mouse 
Mouse 
Pig 
Pig 
Pig 
Pigeon 
Possum 
Rat 
Rat 
Rat 
Rat 
Rat 
Thymus 
Thyroid 
Brain 
Reticulocytes 
Thyroid 
Pancreas 
Liver 
Adipose tissue 
Adrenals 
Adrenals 
Brain 
Ehrlich ascites 
cells 
Difference in inhibitor level between nor-
mal and dystrophic muscle. 
Isolation from cerebral cortex 
Decrease in RNase inhibitor activity on 
fasting. 
Inhibitor present in complex 
Effect of ACTH administration on rat adre-
nal RNase inhibitor. 
Distribution of inhibitor activity over 
different parts of the brain 
Inhibitor activity in nuclear preparations 
Little 
Kraft 
Greif 
Takahashi 
Rost 
Murthy 
Morisset 
Kraft 
Eichel 
Imrie 
Girija 
Suzuki 
Roth 
Chakravorty 
(1970) 
Table II: Alkaline RNase inhibitor in eukaryotes (continued) 
Organism Organ Short Specification Reference 
Rat 
Rat 
Rat 
Rat 
Rat 
Rat 
Erythrocytes 
Heart 
Intestine 
Kidnev 
Kidney 
Liver 
Rat 
Rat 
Rat 
Liver 
Liver 
Liver 
Inhibitor was demonstrated by increased 
RNase activity after treatment with -SH 
reagents 
Increased inhibitor level after unilateral 
nephrectomy 
Presence of inhibitor in the supernatant 
fraction 
Increase in RNA inhibitor level by partial 
hepatectomy 
Decreased inhibitor activity during protein 
deprivation 
Hypophysectomized rats contain twice the 
level of inhibited RNase 
Kraft 
Kraft 
Moriyama 
(1970) 
(1970) 
(1969) 
Rosso 
Roth 
Bishay 
Roth 
Shortman 
Gribnau 
Kraft 
Shortman 
(1973) 
(1956) 
(1974) 
(1956) 
(1961) 
(1970) 
(1972) 
(1962) 
Quir in-Str icker (1968) 
Brewer (1969) 
Table II: Alkaline RNase inhibitor in eukaryotes (continued) 
Organism Organ 
Rat 
Rat 
Rat 
Rat 
Rat 
Rat 
Rat 
Rat 
Rat 
Rat 
Rat 
Rat 
Rat 
Liver 
Liver 
Liver 
Lung 
Lymphocytes 
Muscle 
Parotid Gland 
Reticulocytes 
Serum 
Spleen 
Stomach 
Submandibular 
salivary gland 
Thymus 
Short Specification Reference 
Inhibitor activity in nuclear sap 
Inhibitor activity in nuclear sap 
Inhibitor level decrease in 27-45 week old 
rats, compared to 9 week old rats 
RNase inhibitor was present in parotid 
gland homogenates but not in the secretion 
No change in RNase-RNase inhibitor ratio 
after treatment with phénobarbital 
Decreased inhibitor activity as a result 
of food deprivation 
Inactivation of RNase inhibitor by 9a-fluoro-
prednisolone treatment. EffectofX-irradiation 
Shapot 
Skridonenko 
Kraft 
Roth 
Kraft 
Roth 
Robinovitch 
Goto 
Lechner 
Moriyama 
Moriyama 
Menaker 
Wiernik (1965) 
Table II: Alkaline RNase inhibitor in eukaryotes (continued) 
Organism Organ Short Specification Reference 
Rat Thyroid Murthy (1974) 
Greif (1972) 
Rabbit Reticulocytes Priess (1967) 
Sheep Adrenals Girija (1966) 
Sheep Reticulocytes Girija (1966) 
1.6.4 Presence of inhibitor in cell fractions other than 
supernatant. 
No reports are known in which the distribution of RNase inhi-
bitor activity over different cell fractions has been studied. The 
presence of an inhibitor of alkaline RNase in the nucleus is also 
an unresolved question. Chakravorty and Busch (1967) reported the 
occurrence of an inhibitor of bovine pancreatic RNase in the super-
natant of nuclei obtained after sonification and centrifugation 
at 100,000 g for 1 h. The inhibitor concentration was raised 
2.5 times in the nuclear sap of regenerating liver cells and 
5 times in neoplasmic tissues.The investigated neoplasmic tissues 
were Walker 256 sarcoma, Novikoff hepatoma and Ehrlich ascites 
tumors. 
Also Shapot et al. (1971) reported the presence of an inhibitor 
of alkaline RNase in the nuclear sap of normal liver cells and 
in hepatoma. But the presence of alkaline RNase inhibitor in rat 
liver nuclei was denied by Roth and Juster (1972). The nature of 
the technique employed for nuclei isolation is essential forthis 
discussion , but the methods used by Shapot and Charkravorty were 
also used by Roth. Roth prepared rat liver nuclei in four different 
ways and could not detect any inhibitor activity, free or bound, 
in whole nuclei, sonicated nuclei or in the supernatant fraction 
from sonicated nuclei. 
It is easy to offer a number of reasons to explain the difference 
in results, e.g. contamination by cytoplasmic fragments attached 
to membranes or contamination by adsorption of cytoplasmic compo-
nents during isolation. Co-precipitation of RNA or other artifacts 
may have influences the results of Shapot and Chakravorty. 
In contrast to the findings in rat liver nuclei Roth and Juster 
(1972), referring to a personal communication of Ambellan and Kent, 
reported that these authors failed to find any evidence for an in-
hibitor in rat liver nuclei but did detect RNase inhibitor in thymus 
nuclei. 
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CHAPTER 2 
CHARACTERISTICS OF THE ALKALINE RNase INHIBITOR. 
Despite the fact that RNase inhibí'tor has not yet been isolated 
in quantities suitable for extensive study, a number of its proper-
ties have been reported. However, since most of these studies have 
been carried out with impure preparations, the conflicting results 
may be due to differences in the isolation procedures employed. 
2.1 Protein character of the RNase inhibitor. 
The protein nature of the RNase inhibitor has remained specula-
tive for a number of years. In 1953 an inhibitor of alkaline RNase 
was discovered independently by Roth (1953) and Zöllner (1953). 
This inhibitor was heparin, a polysaccharide with a strongly nega-
tive charge, in which the sulphate groups appear to be essential 
for the inhibiting action on ribonuclease. The same groups are ne-
cessary for the anticoagulant activity. Because heparin is also 
present in relatively large amounts in liver the RNase inhibitor 
activity found in rat liver supernatant was first ascribed to the 
presence of heparin. This idea was rejected for several reasons: 
1. The alkaline RNase inhibitor was much less sensitive to changes 
in ionic strength than was the RNase inhibitory activity of he-
parin (Shortman 1962). 
2. Different behaviour between the two inhibitors was found when the 
pH was lowered. The inhibitory activity of the alkaline RNase 
inhibitor decreased below pH 5.8 but the inhibitory activity of 
heparin is raised at this pH. 
3. The most striking evidence was provided by the action of proteo-
lic enzymes. Low concentrations of papain destroy the rat liver 
inhibitor but the activity of heparin was not affected. Incuba-
tion of the inhibitor with trypsin, pronase and papain causes 
the loss of inhibitor activity (Gribnau 1970). 
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The inhibitor may well be a glycoprotein. This idea is 
perhaps supported by the RNase inhibiting character of heparin and 
-4 -6 the fact that 10 M and 5.10 M periodate has the same effect on 
the inhibitor activity at 0 and 37 С 
2.2. Influence of ions on the inhibitor. 
2.2.1 Effect of sodium chloride. 
Shortman (1962) demonstrated that the activity of the inhibitor 
was much less sensitive to 0.15 M NaCl than was the activity of he­
parin. Studying the effect of the ionic strength on the behaviour 
of the inhibitor it appeared that both the activity of the inhibi­
tor and that of the alkaline RNase was affected. Gribnau et al.(1970a) 
reported that no complex formation could be achieved when 0.15 M 
NaCl was added to the incubation mixture. But higher concentrations 
of NaCl (0.9 M) are reported to be able to dissociate preformed in-
solubilised RNase-RNase inhibitor complexes (Gribnau et al.1970b). 
2.2.2 Effect of magnesium and other metal ions. 
Many metal ions have, in low concentrations (about 1 mM), an 
inhibiting effect on the RNase activity (Goto and Mizumo 1971,Grib­
nau 1970). This causes great problems when the influence of metal 
ions on the RNase inhibitor is being studied. Gribnau et al. (1970a) 
2+ have examined the effect of Mg -ions on ribonuclease and inhibitor 
activity. Mg -ions reduce ribonuclease activity at concentrations 
higher than 50 mM. When MgCl- is added to the incubation mixture 
no significant differences were found in the RNase activity with or 
without addition of inhibitor. Therefore it is important to be sure 
2+ that no Mg is present. Wojnar and Roth (1964) reported a sensiti-
2+ 2+ 
vity of the inhibitor for Cu -and Zn -ions at very low concentra­
tions. The concentrations are too low (up to 0.04 mM) to inhibit 
RNase but the effect on the inhibitor can be clearly demonstrated. 
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Mg -and Ca -ions (0.1 M) should have no effect on the inhibitor 
activity, the findings of Wojnar and Roth (1964) and Gribnau et al. 
(1970a) are therefore contradictory in this respect. 
2+ Inhibition of the inhibitor by Pb was reported by Roth (1958) and 
2+ Shortman (1962); the inhibition by Pb was reversed by H^S (Roth 
1958) and diminished to 50% by addition of 10"2 M EDTA (Shortman1962) 
In view of the data mentioned above metal impurities present in 
some RNA preparations have caused considerable confusion in the 
interpretation of earlier studies on the RNase inhibitor (Wojnar 
and Roth 1964). 
2.2.3 Effect of EDTA. 
As discussed above the inhibitor is sensitive to a number of 
metal ions which may be present in RNA preparations. Because RNase 
is also sensitive to these metal impurities the effect of EDTA on 
the RNase inhibitor system was studied by Ellem and Colter (1963) 
and Gribnau et al.(1970a). Ellem reported an increase in RNase acti-
vity of mouse liver homogenates when incubated in the presence of 
-4 EDTA. Concentrations, lower than 10 M EDTA, give higher RNase acti-
-4 
vity and when tested with 10 M EDTA the liver and kidney prepa-
rations lose all RNase activity. According to Ellem and Colter two 
explanations for this phenomenon are possible: 
1. EDTA could liberate RNase inhibitor from inactive complexes with 
traces of heavy metals and the freed inhibitor could combine with 
alkaline RNase. However, to date, no inhibitor-metal complexes 
have been detected and no studies are known which have revealed 
activation of the inhibitor from inhibitor-metal complexes by 
EDTA. 
2. Because maximal RNase activity increase was measured in liver 
homogenates, this increase was perhaps caused by dissociation 
of the RNase inhibitor complex at concentrations lower than 
-4 10 M EDTA. This suggestion is also not very likely. 
Metal impurities in the RNA preparation may be responsible for the 
unexpected results (compare 2.2.2.). 
22 
Gribnau et al. (1970a) could not detect any dependence of the RNase 
-6 -2 inhibitor system on EDTA concentrations ranging from 10 M to 10 M. 
The rat liver inhibitor used in the test system had been partially 
purified on DEAE-Sephadex. 
2.3. Other reagents affecting the RNase inhibitor activity. 
A number of other components influence the RNase inhibitor 
activity and these will be shown below. 
2.3.1 Effect of sulphydryl reagents on the RNase inhibitor. 
In earlier studies on RNase inhibitor it was noticed that the 
RNase activity could be recovered by adding SH-reagents to the test 
system (Roth 1956, 1958, 1958a). 
When p-chloromercuribenzoate (pCMB) or p-chloromercuribenzene-
sulphonic acid was added to liver preparations the alkaline RNase 
activity increased. A concentration of 1.6 χ IO" M pCMB (final 
concentration in the test system) appeared to be sufficient to give 
complete inactivation of the inhibitor (Shortman 1962). 0-iodoso-
benzoate and N-methylmaleimide in concentrations of 1 mM and mersa-
lyl (0-[ (3-hydroxymercuri-2methoxypropyl ) carbamyl J phenoxyacetic 
acid) at concentrations of 10 M also cause 100% inactivation of 
the inhibitor (Goto and Mizumo 1971a).In a number of reports it has 
been suggestedthat the inhibitor RNase complex is dissociated by 
these sulphydryl reagents. This aspect of the problem will be dis­
cussed in chapter 6. 
No inactivation of the inhibitor was found by treatment with 
-4 -5 
1.3 χ 10 M cysteine, 1.3 χ 10 M cystine (Shortman 1962), 
-3 -3 
iodoacetate (1.0 χ 10 M), oxidized gluthathione (5.0 χ 10 M) 
or 1.0 χ IO"3 M K,Fe(CN)fi (Goto and Mizumo 1971a). 
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2.3.2 Effect of polybasic compounds on the RNase inhibitor 
activity. 
The influence of a number of basic compounds e.g., protamine, 
lysozyme and poly-L-lysine on the inhibitor activity have been stu-
died. 
Protamine prevents the inhibition of RNase by the RNase inhibitor. 
A concentration of 1.0 yg protamine causes 50% inhibition of 1.9 
ribonuclease inhibitor units (Shortman 1962). Also a high concen-
tration (50 yg) of lysozyme in the incubation mixture causes a 
decrease in the inhibitor activity. This inactivation can be ex-
plained by the ability of lysozome to complex with acidic substan-
ces (Shortman 1962). 
Other basic compounds also prevent inhibition of RNase by the 
inhibitor. When poly-L-lysine (molecular weight of 1000-4000 dal-
ton) in quantities of 5-20 y g was preincubated for 5 minutes with 
about 100 \ig of inhibitor from bovine eye lens purified on DEAE-
cellulose (spec.act. 550 U/mg protein), 50% of the inhibition of 
50 ng RNase was lost. A sample of 20 yg of poly-L-lysine incubated 
with 50 ng of RNase had no effect on RNase activity (Ortwerth 1972). 
The polybasic substances described above and others, such as sper-
mine and spermidine have the capacity to interact with the inhibi-
tor. The nature of this interaction is probably electrostatic and 
non-specific. It is known that polycations such as poly-L-lysine and 
protamine inhibit RNase activity by binding to RNA. 
2.3.3 Effect of detergents upon RNase inhibitor activity. 
Sirakov (1971), using the in,000 g supernatant fraction from 
male guinea pig liver, studied the influence of detergents on the 
inhibitor. The detergents, prepared as 0.5-2.0% solutions, had 
little or no effect on the RNase activity, with the exception of 
sodium dodecylsulphate. Also most detergents had little or no ef-
fect on the RNase inhibitor activity, but the inhibitor was inacti-
vated for almost 40% by a 1.0% solution of sodium glycocholate or 
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deoxycholate. However, we could not confirm these results. Deter­
gents which have no effect on the inhibitor were: Tween 20, Tween 40, 
Tween 60, Tween 80, Bry 35, Triton X-100, sodium chelate, saponin 
and digitonin. Combinations of two detergents, of which only one was 
capable of reducing the inhibitor activity, resulted in a diminished 
inhibiting effect of the RNase inhibitor-destroying detergent. The 
combination 0.5% SDS and 1.0% Bry restores the RNase activity at pH 
7.8 while the inhibitor is reactivated for 39%. 
2.4. Specificity of the RNase inhibitor. 
The specificity of the alkaline RNase inhibitor has been studied 
using impure preparations. Shortman (1962) studied the interaction 
between the alkaline RNase inhibitor and various RNases. Rat liver 
supernatant alkaline RNase, rat liver mitochondrial alkaline RNase 
and bovine pancreatic RNase were inhibited by rat liver RNase inhi­
bitor (Shortman 1962). Gagnon (1974) studied the specificity of the 
rat liver ribonuclease inhibitor towards the nuclease activities of 
subcellular fractions. The inhibitor was active against ribosomal, 
mitochondrial and nuclear alkaline RNase. No inhibition could be 
observed towards DNase (Shortman 1962, Gribnau 1970) poly (A) hydro­
lase or phosphodiesterases present in rat liver preparations (Gagnon 
1974). 
Isolated mammalian liver inhibitor is capable to inhibit crytalline 
pancreatic RNase but there is also a cross-reaction possible between 
inhibitor isolated from liver and mitochondrial RNase. 
Cross-reactions occur among the mammalian inhibitors and mitochondrial 
RNase but not between mammalian and non-mammalian species. 
The species used were rat, mouse, guinea pig, frog and chicken 
(Roth 1962). But chicken liver inhibitor which is not active against 
bovine pancreatic RNase was active against "activated" chick super­
natant alkaline RNase (Kraft 1970). 
No inhibition by the RNase inhibitor was obtained for rat liver 
lysosomal acid RNase, RNAse Τ or barley RNase (Shortman 1962). 
Also alkaline RNase with an optimum at pH 9.2, first described by 
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Rahman (1966), is not inhibited by the alkaline RNase inhibitor. 
The available results seem to justify the conclusion that the RNase 
inhibitor is only active against alkaline RNase with an optimum 
at pH 7.8. 
2.5. Kinetic aspects of the RNase-RNase inhibitor interaction. 
2.5.1 Time dependence of the RNase-RNase inhibitor interaction. 
The time necessary for interaction between the inhibitor and 
alkaline RNase in solution is very short. When a constant amount 
of RNase inhibitor was added to the normal test mixture (chapter 
3.5) the percentage of inhibition was constant over the time period 
studied. The incubation time was varied from 5 min to 2 h. Also no 
difference was detected in RNA degradation when RNA was added to 
a mixture containing RNase before the inhibitor was added, but as 
a rule the inhibitor was added first to RNase and thereafter RNA 
was added (Gribnau 1970). 
2.5.2 pH dependence of the RNase-RNase inhibitor interaction. 
The effect of pH on the inhibitor activity had already been no-
ticed by Pirotte (1952). An increased amount of RNase activity 
could be demonstrated after treatment of guinea pig liver super-
natant with 0.25 M HJJSO». The same result was obtained by Roth 
(1956, 1957), who also showed that lowering the pH to 2.3 with 0.05 
M HCl inactivated the RNase inhibitor. No conclusive studies on 
the effect of the pH on RNase-RNase inhibitor interaction and the 
influence of the pH on the dissociation of the RNase-RNase inhibi-
tor complex have been reported. Alkaline RNase is active mainly be-
tween pH 7 and pH 9. Gribnau (1970 ) studied the RNase-RNase in-
hibitor interaction in this pH range; the results revealed that be-
tween pH 7 and pH 8 the percentage of inhibition was constant. 
Above pH 8.0 the percentage of inhibition decreased and about 20% 
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inhibition remained at pH 8.8. 
2.5.3 Effect of concentration of RNase on the RNase-RNase 
inhibitor interaction. 
The relation between the amount of RNase and the amount of in­
hibitor has been discussed by a number of authors (Shortman 1961, 
Gribnau et al. 1970a, Suzuki and Takahashi 1970 and Reignier and 
Buri 1971). It is accepted that there is a linear relationship be­
tween RNase and the inhibitor up to 80-90% inhibition, if the con­
centrations of RNase used are not too large (Shortman 1961, Gribnau 
1970). Buri (1971) demonstrated linearity when low concentrations 
of RNase (up to 0.005 pg/ml) were used, but found that higher con­
centrations resulted in sigmoidal curves. Differences in the per­
centage inhibition were also found when the RNA concentration was 
varied (Buri 1971). When the RNA concentration was raised from 1 mg/ 
ml to 4 mg/ml the percentage of inhibition increased from 15% to ЪОХ. 
The normal concentration of RNA in the assay system used by us was 1%. 
2.5.4 The nature of the inhibition of alkaline RNase by the 
inhibitor. 
Priess and Zi 11 ig (1967) and Ortwerth and Byrnes (1972) found 
Lineweaver-Burk plots which were characteristic of non-competitive 
inhibition. The RNase inhibitor lowers the V of the reaction be­
tween RNase and RNA. Lowering of V is the result of complex for­
mation between RNase and the inhibitor, a complex which is very 
stable, and in which the RNase activity is blocked. The non-compe­
titive character of the RNase-RNase inhibitor reaction is another 
difference between RNase inhibitor and heparin; heparin inhibits 
pancreatic RNase competitively. 
2.5.5 The nature of the RNase-RNase inhibitor linkage. 
The low isoelectric point of the inhibitor, approximately pH 4.5, 
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and the high isoelectric point of RNase, about pH 9.0, makes an 
electrostatic interaction at neutral pH very likely. The inacti-
vation of the inhibitor by polybasic compounds (chapter 2.3.2) also 
supports this concept. 
The identity of the amino acids involved in the interaction was 
investigated by Roth (1966). This author studied twenty different 
chemical derivatives of RNase. Removal of free amino groups from 
RNase did not affect the reaction. Ribonuclease derivatives which 
showed essentially the same reaction with the inhibitor as pan-
creatic ribonuclease included dimethyl aminoaphtalenesulphony! ribo-
nuclease (DNS-ribonuclease), acetylated ribonuclease and 1-CM-
histidine-119-ribonuclease. This last RNase is an interesting one 
since despite the fact that the alkaline RNase activity is lost 
it can still combine with the inhibitor. 
In the presence of 8 M urea the RNase activity is decreased to 70% 
of the value obtained in water and under these conditions no inhi-
bition could be achieved by addition of the inhibitor. This might 
indicate that also hydrogen bonds play a role in the RNase-RNase 
inhibitor interaction. 
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CHAPTER 3 
MATERIALS AND METHODS. 
Materials and methods used for the isolation and characterizat­
ion of the RNase inhibitor and its complex with ribonuclease are 
described in this chapter. 
3.1. Materials 
The following materials were used: 
Acryl ami de 
Amido Black 10 В 
Ampholines 
Bry 35 
Coomassie Brilliant Blue 
DEAE-Sephadex A-50 
Deoxycholate 
Dithioerythreitol 
EDTA 
Gelatin 
2-Mercaptoethanol 
N,N'-methylene-bi sacrylami de 
Labelled amino acids 
Parachloromercuribenzoate (sodium salt) 
RNase ( cryst. bovine pancreatic) 
Sephadex G-25 (fine) 
Sephadex G-100 (particle size 40-120 μ) 
E. Merck A.G. 
E. Merck A.G. 
LKB 
Koch Light Laboratories 
Ltd. 
E. Gurr. Ltd. 
Pharmacia 
E. Merck A.G. 
E. Merck A.G. 
E. Merck A.G. 
Noury Baker 
Koch Light Laboratories 
Ltd. 
E. Merck A.G. 
The Radiochemical Centre 
Amersham 
Fluka A.G. 
C F . Boehringer and 
Soehne 
Pharmacia 
Pharmacia 
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Sepharose Pharmacia 
Media used: 
Medium A; 0.35 M sucrose, 0.05 M Tris-HCl pH 7.6, 0.025 M KCl, 
0.005 M MgCL·, 5 χ 10 M 2-mercaptoethanol. 
Medium В: 0.05 M Tris-HCl pH 7.0, 0 Д M NaCl, Ю - 3 M EDTA 
-3 
5 χ 10 M 2-mercaptoethanol. 
Medium С: 0.05 M sodium phosphate buffer pH 6.0, Ю - 3 M EDTA 
IO"3 M DET. 
3.2. Preparation of subcellular fractions. 
3.2.1 Preparation of cell sap supernatant from calf eye lenses. 
Calf eyes obtained from the slaugther house were used as start­
ing material. After removal, the eyes were stored on ice and trans­
ported to the laboratory. The epithelial cell layer was stripped off 
from the lenses and 1-2 mm of the outer cortex punched out with a 
glass test tube. The material was homogenized in a medium containing 
0.35 M sucrose, 50 mM Tris-HCl (pH 7.4), 25 mM KCl and 5 mM Mg(Ac) 2. 
A glass homogenizer with a Teflon pestle was used for homogenization. 
The homogenate was centri fuged at 12,000 g for 20 min in a Sorvall 
GSA rotor and the supernatant was filtered through 4 layers of cheese 
cloth. DOC was added to the filtered supernatant to a final concen­
tration of 0.55» and the filtrate was layered on a discontinuous 
sucrose gradient according to the procedure of Bloemendal et al. 
(1964). The discontinuous sucrose gradient consisted of 9 ml 2 M 
sucrose and 9 ml 1.5 sucrose, both containing 50 mM Tris-HCl (pH 7.4), 
70 mM KCl and 5 mM Mg(Ac) 2. After centrifugation at 78,000 g for 12 
h in a Spinco ultracentrifuge (Rotor 30) 15-20 ml of the supernatant, 
free of polyribosomes, was pipetted off and stored at -20 С This 
frozen supernatant fraction was used as starting material for the 
isolation of calf eye lens RNase inhibitor. 
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3.2.2 Preparation of liver supernatant. 
The general procedure for the preparation of liver supernatant 
was as follows: after killing the animals, the livers were quickly 
removed and transported in an ice-cold medium consisting of 0.35 M 
sucrose, 0.05 M Tris-HCl (pH 7.6) 0.025 M potassium chloride, 0.005 
M magnesium chloride and 0.005 M 2- mercaptoethanol. The livers were 
washed with the same medium, minced with scissors and homogenized 
with 2 volumes of ice-cold medium. The homogenate, prepared with a 
Teflon-glass homogenizer (5 strokes at 2,000 revolutions per min ) 
was freed from nuclei, mitochondria and cell debris by centrifuga-
tion at 12,000 g for 30 min in a Sorvall GSA rotor. The supernatant 
was decanted and the polysomes were removed either by centri fugati on 
at 10,000 g if the volume was below 100 ml or by precipitation at pH 
5.1 by addition of 1 N acetic acid to the supernatant. The pH 5.1 
precipitate was removed by centrifugation in a Sorvall GSA rotor 
(30 min at 10,000 g). The pH 5.1 precipitation supernatant contain-
ed all RNase inhibitor activity (Bishay 1974 and Bont et al. 1969). 
Other organs (thymus, spleen and adrenals) were processed in the 
same manner. 
3.3 Polyacrylamide gel electrophoresis. 
3.3.1 Polyacrylamide gel electrophoresis at alkaline pH. 
Electrophoresis was performed on cylindrical Polyacrylamide gels 
as described by Bloemendal (1963). A 10% gel was normally used and 
electrophoresis was carried out at pH 8.9 in a Tris-EDTA-boric acid 
system (90.8 g Tris, 9.1 g EDTA and 6.9 g boric acid per liter 
electrophoresis buffer). The gels contained: 10% acrylamide, 0,2% 
N,N' methylene-bisacrylamide, 0.06% TEMED, 0.004% potassium ferri-
cyanide, 0.06% ammonium persulphate and were prepared in the Tris 
EDTA-boric acid buffer. After polymerization the gels were pre-run 
at 3mA per gel for 30 min . 
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Routinely 20-40 μΐ of a solution of 20 mg protein per ml were layer­
ed on top of the gels with the aid of sucrose. Electrophoresis was 
carried out at 2-3 mA per gel tube and the run was terminated when 
the tracking dye (Bromophenol Blue) reached the end of the gel. 
After the run the gels were removed from the glass tubes and stain­
ed for 30 min in a solution containing 0.5% Amido Black В in 7% 
acetic acid and 50% methanol. Destaining was carried out by electro­
phoresis (200 V) perpendicular to the length of the gels in a 2% 
acetic acid solution. Alternatively the gels were cut in 0.5 cm or 
2 ran slices and used in the RNase inhibitor test system. 
3.3.2 Polyacrylamide gel electrophoresis at alkaline pH in 
6 M urea. 
Electrophoresis at alkaline pH in 6 M urea was performed in the 
electrophoresis system described in 3.3.1 but all solutions were 
prepared in 6 M urea from which cyanate ions had been removed by 
passage over a Dowex-50 column. 
3.3.3 Isoelectrofocusing in Polyacrylamide gels. 
Polyacrylamide gels for isoelectrofocusing were prepared as 
described by Wrigley (1968). The isofocusing gels contained: 
6.3% acrylamide, 0.17% N.N' methylene-bisacrylami de, 0.06% TEMED, 
0.8% Ampholines pH 3-10. The electrode solutions consisted of 0.4% 
tri ethanol ami ne and 0.2% H?S0., respectively. 
The gels were polymerized with anmonium persulphate. An ampholyte 
layer (0.05 ml 40% Ampholine in 2 ml HpO, in which 100 mg sucrose 
was dissolved) was placed on the top of the gel. The gels were pre-
run at 350 V for 30 min after which the buffers were changed and a 
sample was applied on top of the gel. The ampholyte solution was care­
fully layered over the sample layer and the buffer for the electro­
phoresis chamber was applied without disturbing the ampholyte layer. 
Electrophoresis was carried out for 3.5 h at 1 mA per gel and 350 V 
and staining was performed according to the procedure of Malik (1972). 
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3.3.4 SDS Polyacrylamide gel electrophoresis 
SDS gel electrophoresis was carried out according to the method 
of Laemmli (1970). The SDS gels contained: 15% acrylamide, 0.4% Ν,Ν' 
methylene-bisacrylamide,0.38 M Tris-HCl pH 8.8, 0.1% SDS, 0.002% 
TEMED and 0.02% persulphate. The samples were sol ubi li zed in 2% SDS, 
1% 2-mercaptoethanol and 0.063 M Tris-HCl pH 6.8. The electrode solu­
tions consisted of Tris-HCl pH 8.3, 0.1% SDS and 1% 2-mercaptoetha­
nol. Before use 50 μΐ of a stacking gel (3% acrylamide at pH 6.8) 
was applied on top of the spacer gel. The samples were heated at 
100 С for 3 min before layering on top of the gel. The run was ter­
minated when the tracking dye (Bromophenol Blue) reached the bottom 
of the gel and staining was performed with a Coomassie Brilliant Blue 
solution (0.25% Coomassie Brilliant Blue in 45% methanol, 45% water 
and 10% acetic acid). As markers, bovine serum albumin, ovalbumin, 
chymotrypsinogen A and RNase were used. 
3.3.5 Polyacrylamide gel electrophoresis at acid pH. 
10% Polyacrylamide gels at pH 3.9 were prepared in 8.0 χ 0.5 cm 
cylindrical glass tubes. The gels contained: 10% acrylamide, 0.27% 
bisacrylamide, 4% 1 Ν K0H, 1.4% acetic acid, 0.05% TEMED and 0.05% 
ammonium persulphate. The electrode buffer consisted of 6.24 g of 
B-alanine and 1.6 ml concentrated acetic acid per 100 ml. Methylene 
blue was used as tracking dye and after electrophoresis the gels were 
stained with an 0.5% Amido Black solution in 7% acetic acid and 50% 
methanol and destained electrophoretically in 2% acetic acid. 
3.4. Isoelectrofocusing in columns. 
In an isoelectrofocusing column (LKB 8100, volume 110 ml) a 
density gradient of sucrose (0-30%) was prepared containing 2% am-
pholine.pH 3-6. To the light solution (ampholine and water) Bry 35 
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(1% final concentration) was added. The heavy solution (sucrose, 
ampholine and water) in which the protein sample was dissolved, 
contained the same Bry 35 concentration. This non-ionic detergent 
was added to prevent precipitation during the run (Friesen 1972). 
Electrophoresis was carried out at 2 C; a voltage of 450 V was 
applied for two days. 
3.5. Preparation of RNase coupled to Sepharose 4B. 
10 ml Sepharose was mixed with an equal volume of distilled 
water and finely divided CNBr was added. During the reaction the 
pH was kept at 11 with 2 N NaOH; the reaction time was 8 min 
and the reaction temperature was about 20 С After 8 min ice 
was rapidly added to the activated Sepharose and the suspension 
washed with cold 0.1 M NaHC03 and cold distilled water. The acti­
vated Sepharose was transferred to a beaker containing an excess 
of 3,3' diaminopropylamine previously brought to pH 10 with 6 N 
HCl. After reaction for 16 h at 4 C, the Sepharose was washed 
with about 7 liters of cold distilled water. The aminopropyl-Sepha­
rose was treated with succinic anhydride or adipic acid (one milli-
mole of either reagent per ml ami nopropyl-Sepharose), and the 
pH was then maintained at pH 6.0 by adding 20% NaOH. When the pH 
was constant, the reagent mixture was left for 5 h at 4° C. The 
water washed succinylaminopropyl-Sepharose was suspended in water ..nd 
then RNase was added. The pH of the reaction mixture was 5.0 which 
was achieved by adding 1 N HCl. 750 mg l-ethyl-3-(3 dimethyl amino­
propyl ) carbodiîmide, dissolved in 4 ml H?0 was added over a period 
of 5 min. The mixture was allowed to react for 20 h at room tempe-
rature. The binding of the amino and carboxylic acid containing 
molecules can easily be checked by a simple colour test. One ml of 
saturated sodium borate is added to the modified Sepharose and a 
few drops of a 3% aquaous solution of sodium 2,4,6,-trinitrobenzene 
sulphonate are added. The reaction is normally completed within 1 h. 
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R e a c t i o n Scheme 1 . 
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With the above method the length of the spacer can easily be varied; 
the spacer can be lengthened by repeating the coupling procedure. 
(see: Reaction Scheme 1). 
3.6. RNase inhibitor assay and RNase-RNase inhibitor determination. 
3.6.1 RNase inhibitor assay. 
RNA was prepared according to the method of Crestfield et al.(1955). 
About 200 g of Bakers yeast (Saccharomyces cerevisiae) was suspen­
ded in 500 ml of a boiling solution consisting of 0.0125 M NahLPO^, 
0.0125 M Na 2HP0 4 (pH 6.6), It SDS and 4.5% ethanol. The suspension 
was heated further for 5 minutes and then rapidly cooled in a 
freezing mixture of solid carbon dioxide and acetone. The suspen­
sion was stirred until the temperature dropped to approximately 
40C. The mixture was centri fuged at 2,000 rpm for 30 min at 40C 
in a Servali GS-3 rotor. 
The solution was poured into two volumes of ice-cold ethanol while 
stirring, the precipitate was allowed to settle and the clear super­
natant was decanted. The precipitate was collected by centrifuga-
tion at 2,000 rpm at 40C for 30 min in a Sorvall GS-3 rotor. 
The collected precipitate was then washed with two 200 ml portions 
of cold 67 per cent ethanol to which 0.3 ml of 2 M NaCl had been 
added to ensure flocculation and good recovery. The crude nucleic 
acids were suspended in cold 80 per cent ethanol and the solution 
was placed overnight in a cold room. The nucleic acids were collec­
ted by centri fugati on and dissolved in about 400 ml water (2 kg of 
yeast was routinely used for this RNA preparation). On solution the 
pH was brought to neutral with 1 N acetic acid. The turbid solution 
was clarified by centrifugation for 2 h at 10,000 rpm and 4 С The 
supernatant was cooled to 2° С in ice and at this temperature solid 
sodium chloride was added to a final concentration of 1 M. On stan­
ding both the turbidity and the viscosity increased. In about 20 
min a gel appeared which was collected by centrifugation 
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(30 min at 2,000 rpm 4° С in a Sorvall GSA rotor). The gel was washed 
with two 150 ml portions of cold 67 per cent ethanol, to each of which 
1 ml 2 M solution of NaCl had been added. The washed precipitate was 
dissolved in water and dialyzed against three changes of 10 1 distil­
led water. The dialysed RNA was then lyophilized. Starting with 2 kg 
yeast the yield was usually about 6 g RNA. 
The RNA was dissolved in distilled water to a concentration of 1%, 
assuming that RNA at a concentration of 1 mg per ml had an extinc­
tion of 25 at 260 nm. 
Crystalline pancreatic RNase (Boehringer) was dissolved in 0.1% 
gelatin solution to a concentration of 0.05 ug/ml. The gelatin so­
lution employed was pretreated first by dialysis against 0.01 M 
EDTA, to remove heavy metal ions, then against 0.15 M sodium chlo­
ride and finally against 3 changes of distilled water. The RNAse 
solution was stored in small portions at -20° C. 
The inhibitor activity was measured according to the method des­
cribed by Gribnau (1970). The incubation mixture contained 100 yl 
of a suitable dilution of the inhibitor sample to be assayed, 100 
ul of the RNase solution and 200 μΐ of 0.05 M Tris-HCl buffer,pH 
7.8. Finally 200 μ! of the RNA solution (1%) was added. The mix­
ture was incubated for 30 min at 37 С The reaction was stopped 
by addition of 0.6 ml of 1 N HCl in Ibt ethanol. After centrifu-
gation at 2,000 g for 20 min at 4° С an aliquot of 0.5 ml of the 
cleared supernatant was pipetted off and diluted with 2.5 ml of dis­
tilled water. The absorbance at 260 nm was measured in 0.5 cm cu­
vettes. Activity determinations of 0.005 yg of bovine pancreatic 
RNase in the absence of inhibitor were run simultaneously with 
blanks without RNase. 
One unit of inhibitor is defined as the amount which causes 50% 
inhibition of 0.005 yg RNase under the standard conditions des­
cribed. 
3.6.2 Determination of the RNase-RNase inhibitor complex. 
The presence of RNase-Rnase inhibitor complex was determined 
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by measuring the difference in RNase activity in the presence and 
absence of pCMB. The test assay consisted of 100 yl sample, 100 μΐ 
H20 or ΙΟ"
3
 M pCMB, 200 yl Tris-HCl buffer pH 7.8 and 200 μΐ 1% 
RNA solution. pCMB destroys the inhibitor activity, but has no 
effect on the RNase activity. 
3.7. Preparation of radioactive RNase. 
Male Wistar rats, weighting about 200 gram, were injected with 
pilocarpine nitrate dissolved in saline (4 mg/100 g body weight) 
and killed 2 h after treatment (Kramer and Poort 1968). The pancreas 
was isolated after decapitation of the rat and cut into slices of 
1 mm thickness. The slices were washed with incubation mixture and 
centrifuged for 5 min at 37 С The incubation mixture was a Krebs-
Ringer bicarbonate buffer in which the KCl concentration had been 
increased to 13 mM, and all amino acids (except the radioactive ami­
no acids) and glucose were added in about the same concentrations 
as present in rat plasma (v.Venrooy et al.1972). During preincuba­
tion and incubation the solution was continiously gassed with a 
mixture of 95% 0« and Ъ% CO^ and gently shaken at 37° С After cen­
tri fugati on the pancreatic fragments were resuspended in the same 
medium but now completed with the missing amino acids. When RNase 
was to be labelled with tritium, radioactive Tyr, Lys, Ser and Val 
35 (0.1 m С of each) were added; for [ S] labelling methionine was 
used. After incubation (30-45 min) at 37 С the fragments were washed 
extensively with ice-cold Hanks solution. 
Rat pancreas RNase was isolated as described by Beintema et al.(1973). 
After homogenization of the fragments in 0.125 M Н?50д, with a teflon-
glass homogenizer, the homogenate was allowed to stand for at least 
2.5 h at 4 С After centrifugation 4 volumes of cold acetone were 
added to the supernatant; the precipitate was collected by centrifu­
gation and lyophilized. The material was suspended in 5 times its 
weight of water and well mixed. The suspension was centrifuged and 
solid ammonium sulphate was added until 60% saturation was reached. 
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The supernatant was then brought to 70% saturation with solid 
(NH.)? SO-. The clear supernatant was subsequently brought to full 
saturation with (NH.USO. whereupon the RNase precipitated. The 
70-100% (NHJ-SO- precipitate, containing the RNase, was collected. 
The precipitated proteins were dissolved in 0.1 M glycine-HCl buf-
fer pH 3.5 containing 0.1 M NaCl, 0.1 M EDTA and 0.01% gelatin. 
The RNase fractions were desalted by gel filtration on a Sephadex 
G-25 column and were loaded on a carboxymethyl-cellulose column 
(CM-52) equilibrated in 0.01 M phosphate pH 6.05. RNase was iso-
lated using a phosphate gradient of 0.01 M pH 6.05 to 0.1 M pH 7.5. 
The RNase containing fractions were dialysed and lyophilized. The 
RNase was then dissolved in 0.05 M tri ethyl ami ne adjusted to pH 
7.0, freed from salt by passage over Sephadex G-25 equilibrated 
in the same buffer, and lyophilized. Labelled RNase, prepared with 
this method, retains its activity and contained no labelled impu-
rities after SDS Polyacrylamide gel elctrophoresis and electropho-
resis at pH 3.9. 
3.8. Determination of protein concentrations. 
Protein was determined according to the method of Lowry et al. 
(1951) using bovine serum albumin as a standard. 
A second method used has been described by Waddell and Hill (1956). 
Protein samples are diluted with saline (0.9% NaCl) and the absor-
bance measured at 225 nm subtracted from that at 215 nm. This dif-
ference multiplied by 144 gives the protein concentration in the 
diluted solution expressed in micrograms per ml. 
In this method the absorbance should not exceed 1.5. 
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CHAPTER 4 
ISOLATION OF THE RNase INHIBITOR. 
4.1. Introduction. 
Pirie (1950) demonstrated indirectly the existence of an RNase 
inhibitor by the finding of a latent RNase activity, but Pi rotte 
and Desreux (1952) were the first to describe the occurrence of an 
RNase inhibitor in the 150,000 g supernatant fraction from guinea 
pig liver. Since then a number of attempts have been made 
to isolate the inhibitor but no reports are known which deal with 
the isolation of an active and homogeneous preparation. 
The procedure, described here, is set up for calf eye lens RNase 
inhibitor but can be used, with minor modifications, for various 
other organs. The chromatographic method is mainly based on the 
results obtained by Gribnau (1970) and other investigators (Roth 
1958 and Shortman 1961). 
4.2. Purification of the RNase inhibitor from calf eye lens. 
4.2.1 Starting material. 
Up to now the most commonly used starting material has been 
rat liver, but the inhibitor •¡<- only a minor component of the to-
tal protein. This is, as compared with the DNase inhibitor, a great 
difference, because the latter inhibitor represents 5-10% of the 
soluble protein from thymus cells (Lindberg 1966). 
We chose calf eye lens as starting material, because the RNase 
inhibitor is present in relative abundance, as will be shown, and 
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because the calf eye lens supernatant could be easily obtained. 
The distribution of the inhibitor in the lens is not equal over 
the different regions of the lens. The greatest quantity, about 
95%, is found in the cortex, but the highest specific activity 
is found in the epithelial layer. The distribution of the inhi-
bitor over the different lens zones, as reported by Ortwerth and 
Byrnes (1971) is given in table III. 
Table III: Distribution of RNase inhibitor over different calf 
eye lens zones (from Ortwerth and Byrnes,1971). 
% of the total activity spec.act. 
Epithelium layer 1.8 14 
Cortex 97.2 5 
Nucleus 1.0 0.05 
x
 the specific activity is given in units/absorbance unit at 280 nm. 
The distribution of the inhibitor over the calf eye lens regions was 
also studied by Gross et al. (1970), who likewise found the highest 
specific activity in the epithelial layer. The highest increase of 
RNase activity, after treatment with pCMB, was demonstrated in the 
epithelium. No increase in the alkaline RNase activity was detected 
in the cortex, indicating that RNase in the complex form is absent. 
Because the eye lens cortex contains little alkaline RNase it 
possesses the greatest part of the inhibitor in an uncomplexed form. 
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Besides the absence of 
an organ rich in RNase inhibitor, a second negative factor is that 
organs usually contain alkaline RNase and after homogenization 
of the tissue, only the excess inhibitor can be isolated. Until 
now, no procedures have been described starting with dissociation 
of the RNase-RNase inhibitor complex. 
4.2.2 Theoretical purity. 
If we assume that the RNase-RNase inhibitor ratio in the complex 
as in the case of the trypsin «.-antitrypsin complex and the DNase-
DNase inhibitor complex is unity, we can calculate the highest theo-
retical purity reachable. 
One unit of inhibitor is defined as the amount which will cause 
50% inhibition of 0.005 ug RNase under standard conditions: 
1 Unit of inhibitor will therefore react with 0.0025 \ig RNase 
or, 400,000 U of inhibitor will bind 1 mg of RNase. 
Since 1 mg RNase,mol weight 14,000 dalton, can bind about 4 mg 
inhibitor (mol. weight inhibitors55,000 dalton) the highest reach-
able purity is, if the assumption of the one to one complex is 
correct, 100,000 U per mg protein. 
4.2.3 Purification of RNase inhibitor from calf eye lens 
supernatant. 
4.2.3.1 Ammonium sulphate precipitation. 
To the 100,000 g supernatant, prepared as described in section 
3.1., solid ammonium sulphate was added. Fractions were prepared 
by precipitation between 0-10%, 10-20%, 20-30% etc., until 100% 
saturation was reached. After addition of the solid ammonium sul-
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phate the suspension was stirred at 4 С The precipitates were 
collected by centrifugation at 10,000 g and suspended in 50 ml 
medium В containing the highest ammonium sulphate concentration. 
After washing for 30 min the precipitates were pelleted again by 
centrifugation and medium В was added until the precipitates dis­
solved. 
The dissolved protein was dialysed against three changes of the 
same medium and the inhibitor activity was determined with the in­
hibitor assay (section 3.5). The results are given in fig.l. 
% of total inhibitoi activity 
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Fig.l. RNase inhibitor activity present in 
ammonium sulphate precipitation fractions. 
Fractionation of the eye lens supernatant 
was carried out as described in the text. 
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At least 80% of the RNase inhibitor activity present in the super­
natant precipitated between 30 and 40% saturation. The fractions 
precipitating between 20-30% and 40-50% saturation contained some 
inhibitor activity. Unfortunately the fraction precipitating be­
tween 30 and 40% saturation contains almost all of the tissue pro­
teins and therefore the actual purification reached by this step 
is rather low. But the precipitation provides a convenient method 
of concentrating the protein from the bulk quantities of eye lens 
supernatant. 
The ammonium sulphate precipitate dissolved in medium B, was desal­
ted on a Sephadex G-25 column (120 χ 7 cm) equilibrated in 
medium B. The protein fractions emerging with the void volume of 
the column were combined. Routinely, the isolation procedure was 
started with 400 ml of 100,000 g supernatant. The 30-40% ammonium 
sulphate precipitate contained 20-40 g of protein. 
4.2.3.2 Chromatography on DEAE-Sephadex A-50. 
The desalted protein fraction obtained after gel filtration on 
Sephadex G-25 was directly loaded onto a column of DEAE-Sephadex 
A-50 (20 χ 5 cm) equilibrated in medium B. Under these ionic con­
ditions about 70% of the total protein remained unbound. Next the 
column was washed with medium В supplemented with 0.05 M NaCl until 
the absorbancy at 280 nm decreased to 0.05. After washing, the 
inhibitor was eluted by developing a linear NaCl concentration gra­
dient prepared by mixing 750 ml medium В with 0.15 M NaCl, and 750 
ml medium В containing 1.0 M NaCl. The elution was performed at 
4 С and fractions of about 7 ml were collected. 
A typical elution pattern is shown in fig.2. 
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Fi g. 2. Chromatography on DEAE-Sephadex A-50. 
The 30-40% ammonium sulphate fraction was, after 
desalting, loaded onto a column of DEAE-Sephadex 
A-50, equilibrated in medium B. After washing of 
the column, a linear gradient was started ranging 
from 0.15 M to 1.0 M NaCl in medium B. The first 
fraction containing RNase inhibitor was eluted 
at a concentration of approximately 0.25 M NaCl. 
o-o absorbance at 280 nm 
t-· absorbance at 260 nm 
x-x RNase inhibitor activity in U/ml 
All fractions were tested for inhibitor activity in a 10-fold dilu­
tion. The active fractions containing at least 200 U/ml were collec­
ted, dialysed against 3 changes of 10 1 water and lyophilized. The 
quantity of protein obtained after lyophil ization was 150-300 mg 
with a specific activity varying from 100 U/mg to 550 U/mg protein. 
4.2.3.3 Gel filtration on Sephadex G-100. 
One hundred mg of the lyophil i zed material obtained after DEAE-
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Sephadex A-50 chromatography was dissolved in a small volume of 
medium С Insoluble material was removed by centrifugation. The 
clear supernatant fraction was loaded onto a column packed with 
Sephadex G-100 (120 χ 2.8 cm) equilibrated in medium С Elution 
was accomplished with medium С at a flow rate of about 30 ml 
per hour. The bulk of the proteins applied to the column emerged 
in the void volume. 
This protein fraction revealed some inhibitor activity but this 
was only a very small percentage of the total inhibitor activity. 
The activity present in this fraction is perhaps the result of 
aggregation of the inhibitor or association with other proteins, 
without loss of the inhibitor activity. The inhibitor activity 
was located between the 40,000 and 70,000 dalton region. A typi­
cal elution profile is given in fig.3. 
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Fig.3. Gel filtration on Sephadex G-100 of the DEAE-Sephadex 
RNase inhibitor fraction. Lyophilized DEAE-Sephadex RNase in­
hibitor fraction was applied to a column of Sephadex G-100 
equilibrated in medium C. Elution was performed with the 
same medium. Arrows indicate the volume of the reference 
compounds; V=Void volume (Dextran Blue), B= bovine serum 
albumin (mol. w. 68,000), 0= ovalbumin (mol. w. 45,000), 
C= chymotrypsinogen A (mol. w. 25,700), R= RNase (mol. w. 
13,700). ·-· absorbance at 280 nm. o-ö RNase inhibitor act. 
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In general the recovery in this purification step was good and the 
specific activity increased to 5,000-10,000 U/mg protein. The active 
fractions were usually combined and immediately used for further 
experiments. The inhibitor activity decreased rapidly on storage 
at 4° С and it was not possible to dialyse and lyophilize the Sepha-
dex G-100 purified inhibitor without loss of its activity. Normally 
the inhibitor containing protein fractions consists of a large num­
ber of proteins which could be demonstrated by electrophoresis in 
an SDS containing gel system. 
The protein eluted in the 20,000 dalton region is F.M-crystallin 
(v.d.Broek 1973), previously called pre ct-crystallin, which is al­
most pure after Sephadex G-100 chromatography. 
The standard purification procedure is summarized in table IV: 
Table IV: Standard purification of calf eye lens inhibitor. 
Purification step Protein(mg) Total units Spec.act.U/mg 
prot. 
Supernatant fraction 20,000-40,000 400,000-800,000 10-20 
30-40% amm.sulphate 14,000-34,000 400,000-700,000 10-30 
precipitate 
DEAE-Sephadex A-50 150-300 60,000-120,000 150-650 
fraction 
Sephadex G-100 3-10 30,000-80,000 5,000-10,000 
fraction 
Starting from the eye lens supernatant fraction the yield of protein 
and units of RNase inhibitor after each purification step is given. 
The protein concentrations have been determined with the Lowry (1951) 
method and the procedure of Waddell and Hill (1956). 
The protein patterns of the DEAE-Sephadex purified and Sephadex 
G-100 purified inhibitor preparations after electrophoresis at al­
kaline pH, which was carried out as described in chapter 3, are shown 
in fig.4.
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Fig.4. Polyacrylamide gel electrophoretic patterns 
of RNase inhibitor fractions after electrophoresis 
at pH 8.9. 
gel 1: DEAE-Sephadex purified inhibitor. 
gel 2: Sephadex G-100 purified inhibitor. 
The inhibitor activity is indicated with an arrow. 
4.3. Methods used for préparation of highly purified calf eye 
lens RNase inhibitor. 
A number of methods were tried for the further purification of 
the inhibitor preparations.Two of these will be discussed hereafter. 
4.3.1. Affinity chromatography. 
4.3.1.1. Introduction. 
Currently this method is generally accepted as a very useful 
tool for high purification of proteins. This method has been des-
cribed extensively in a number of reviews ( Turkova 1974, Cuatre-
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casas 1972). At present various commercial preparations are avail­
able which contain RNase coupled to a solid matrix. The backbones 
employed are CM-cellulose, Sepharose 4B or Polyacrylamide. All 
colmerei ally available preparations have RNase directly bound to 
the matrix. Some of the commercial preparations, in which RNase 
is bound directly to a solid matrix, have the disadvantage that 
large amounts of RNase are removed by simple washing. Up to now 
there have been two reports describing the use of affinity chroma­
tography for the isolation of the RNase inhibitor (Gribnau 1970 
and Gagnon 1973). 
When RNase-CM cellulose columns are washed till they lose no more 
RNase, the final capacity to bind RNase inhibitor is extremely low. 
The quantity of inhibitor which can be bound is about 8,000 units 
per gram RNase-CM cellulose (Enzite) (Gribnau 1970 and Gagnon 1973). 
The purity achieved by Gagnon (1973) was 15,000 U/mg protein. This 
specific activity can occasionally be obtained by purification on 
DEAE-Sephadex A-50 and Sephadex G-100. The results obtained with 
RNase-CM cellulose are poor and a possible explanation for this 
limited capacity may be that the RNase region necessary for inter­
action with RNase inhibitor is less accesible. One possible expla­
nation of this is that the binding site is too close to the solid 
phase and any tight interaction is excluded. This steric factor has 
played an important role in the isolation of a number of proteins. 
The low binding capacity of the Enzite (RNase bound to CM-cellulose) 
preparation therefore could perhaps be improved by an increased 
distance between the RNase and the matrix. Good results have been 
obtained with "spacers" placed between the matrix and the binding 
substrate for α-chymotrypsin, ß-galactosidase, tyrosine aminotrans-
ferase and acetylcholinesterase (Cuatrecasas 1972). 
4.3.1.2 Results. 
In the last few years a number of methods have been developed 
for binding proteins to a solid matrix.In the procedure developed 
by Kay and Lilly (1970) 2-amirio-4,6 dichloro-5-triazine is coupled 
49 
to the hydroxy! groups of Sepharose and the second chloro-group 
can react with the ami no-groups of the protein. With the glutaral" 
dehyde method, described by Weston and Avrameas (1971), a longer 
spacer was placed between the Polyacrylamide backbone and RNase; 
glutaraldehyde, in excess, reacts via one of its two aldehyde groups 
with the free amino or amide groups present in Polyacrylamide gels 
(Biogel P-300); the remaining free aldehyde group is available for 
combination with an amino group of RNase, which is added subsequently. 
Although RNase could be bound succesfully to the matrix using these 
two methods, we were not able to isolate active, purified inhibitor 
from these columns. 
Another method, succesfully employed by Cuatrecasas (1970) was used 
for coupling RNase to Sepharose 4B. We have used this method, des­
cribed in more detail in section 3.4, and the employed spacers were 
built up by diaminopropylamine and succinic acid or adipic acid. 
The RNase-Sepharose 4B column was equilibrated in medium С 
Also the results obtained with the latter method were very disap­
pointing. Usually no inhibitor activity could be detected in the 
fractions colllected after elution of the samples with the equilibra­
tion buffer, so all inhibitor was either bound to the column or was 
inactivated. In the protein pattern of the non-bound protein fraction 
the specific inhibitor band (section 4.3.2.1) was lacking after Poly­
acrylamide electrophoresis at pH 8.9. 
However, after washing of the RNase-Sepharose 4B column with medium 
С only low inhibitor activities could be recovered in the fractions 
obtained following elution with high sodium chloride concentrations 
(up to 5 M) or pH gradients. Exceptionally, very active preparations, 
up to 75,000 U per mg of protein, were isolated. But the top fractions 
obtained after chromatography of the inhibitor on Sephadex G-100 some­
times also revealed a specific activity of 30,000-40,000 U per mg of 
protein. 
4.3.2. Isolation of the RNase inhibitor by Polyacrylamide 
gel electrophoresis. 
Since the isolation of the inhibitor could not be achieved 
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satisfactorily by affinity chromatography an electrophoretic method 
was used. 
4.3.2.1 Determination of RNase inhibitor activity on Polyacrylamide 
gels. 
Inhibitor preparations obtained after DEAE-Sephadex A-50 chroma-
tography were loaded on top of an alkaline Polyacrylamide gel (Tris-
EDTA-boric acid buffer pH 8.9). Electrophoresis was performed at 
2-3 mA per gel tube with Bromophenol Blue as tracking dye. Some 
gels were stained with Amido Black while others, run simultaneously, 
were cut in sections and tested for inhibitor activity. The gel 
pieces (2 or 5 mm) were minced and 100 yl KLO and all 
further components necessary for the RNase inhibitor assay were added 
(section 3.5.1). The RNase inhibitor activity could be determined 
without any preincubation. A typical result is shown in fig.5. 
The RNase inhibitor activity, under our experimental conditions, 
was mainly present in a fraction located roughly in the middle of 
the Polyacrylamide gel. Some inhibitor activity could also be detec-
ted on top of the gel. 
4.3.2.2 Preparation and isolation of the protein band containing 
the RNase inhibitor activity. 
The inhibitor activity containing protein was isolated with the 
aid of a water-cooled preparative electrophoretic apparatus type 
A 14700 (supplied by Pleuger, Wynegem, Belgium) holding 12 tubes 
of 16 cm length and a diameter of 1.2 cm. After electrophoresis in 
a Tris-EDTA-boric acid buffer, pH 8.9 for 9 h at 5 mA per gel, a 
thin strip of the gel obtained by longitudinal slicing was stained 
with Amido Black in order to localize the inhibitor. 
The unstained part of the preparative gel, containing the inhibitor, 
was extracted with 0.1 M Tris-HCl,pH 7.8. The gel was divided into 
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Fig.5. RNase inhibi'tor activity after gel electro­
phoresis at alkaline pH. 200 yg DEAE-Sephadex purified 
RNase inhibitor from calf eye lenses was loaded onto 
an alkaline Polyacrylamide gel and electrophoresed. 
After the electrophoretic run one gel was stained 
with Amido Black 10 В and another gel, run simul­
taneously, was divided into 0.5 cm sections and 
tested for RNAse inhibitor activity as described 
in chapter 3. 
very small pieces with a razor blade before extraction. The extrac­
ted material was dialysed, lyophilized and dissolved in the same 
Tris buffer. Gel material was removed by centri fugati on at 5000 g 
and the supernatant was lyophilized after dialysis. The protein 
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obtained in this way was used for further examination. 
4.3.2.3. Homogeneity on basic urea-polyacrylamide gels. 
The isolated RNase inhibitor was applied on top of an alkaline 
gel (Tris-EDTA boric acid pH 8.9) prepared in 6 M urea. Upon electro-
phoresis only one protein band appeared after staining either with 
Amido Black or Coomassie Brilliant Blue. Electrophoresis in 6 M urea 
shows that the inhibitor preparation contained no other proteins 
migrating with a different electrophoretic mobility in this Poly-
acrylamide gel system. The pattern demonstrates that the RNase inhi-
bitor protein does not dissociate in the 6 M urea gel system 
(fig.6). 
4.3.2.4. Homogeneity on isoelectric focusing Polyacrylamide gels. 
The isolated protein was applied on top of a Polyacrylamide gel, 
in which a pH gradient was prepared ranging from pH 10 (top) to pH 
3 (bottom). After electrophoresis and staining (Malik and Berrie 
1972) only one protein band was visible (fig.6). 
When the protein band containing the RNase inhibitor activity was 
extracted from the preparative alkaline gel after staining with 
Amido Black and the extract subsequently loaded onto an isofocusing 
gel, again only one protein band was visible. However, the electro-
phoretic properties of the protein extract had changed, most pro-
bably because of the Amido Black which has been reported to bind 
to the basic groups of proteins (Racusen 1973). This result is not 
shown. 
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Fi g.6. Polyacrylamide electrophoresis of purified 
inhibitor. After extraction of the RNase inhibitor 
activity containing gel fraction, the dialysed and 
lyophilized protein was applied onto an alkaline 
gel containing 6 M urea (right gel). On an isofo-
cussing gel, ranging from pH 10 (top) to pH 3, 
the extracted protein resulted in the pattern 
in the left gel. 
4.4. Electrophoretic identity of the RNase inhibitor isolated 
from different organs. 
The electrophoretic behaviour of the RNase inhibitor isolated 
from 6 different organs was compared. 
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4.4.1 Purification of the RNase inhibitor from other organs. 
4.4.1.1 Isolation of inhibitor from calf liver. 
Calf liver was homogenized in medium A freed from fast sedimen-
ting particles at 10,000 χ g. The supernatant was acidified to pH 
5.1 with 4 N acetic acid stirring and the resulting precipitate was 
pelleted by centrifugation. Solid ammonium sulphate was added to the 
supernatant until 50% saturation was reached. The 0-50% precipitate 
was collected by centrifugation in a GSA-rotor in the Son/all 
centrifuge (10,000 g for 30 min at 4° С). The precipitate was 
dissolved in medium В pH 7.0 and desalted on Sephadex G-25 equili­
brated in the same medium. The desalted protein was loaded onto 
a DEAE-Sephadex A-50 column and the inhibitor was obtained by de­
veloping a linear salt gradient ranging from 0.15 M NaCl to 1.0 M 
NaCl in medium B. The inhibitor fractions were colllected, dialysed 
and lyophilized. 
4.4.1.2 Isolation of inhibitor from rat liver. 
After homogenization of rat liver in medium A,polysomes were re­
moved by centrifugation at 100,000 g for 2 h.The inhibitor containing 
fraction precipitated between 35-65% ammonium sulphate saturation. 
After desalting on Sephadex G-25, the inhibitor was isolated 
by developing an NaCl gradient after adsorption onto a DEAE-Sephadex 
A-50 column (Gribnau 1970 ). 
4.4.1.3 Isolation of inhibitor from sheep adrenal. 
Inhibitor from sheep adrenal was isolated by a procedure iden­
tical to that used for rat liver. After homogenization of the sheep 
adrenals in medium A, polysomes were removed by centrifugation at 
100,000 g. By addition of solid ammonium sulphate the fraction pre­
cipitating between 35 and 55% saturation was collected (Girija 1966). 
After desalting, the protein fraction was applied onto a DEAE-
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Sephadex A-50 column. The inhibí'tor was isolated with the aid of a 
NaCl gradient. 
4.4.1.4 Isolation of inhibitor from rat thymus and rat spleen. 
After homogenization of the organs and removal of the polysomes, 
the inhibitor-containing protein fraction was isolated with ammonium 
sulphate. The fraction precipitating between 30 and 65% saturation 
was further purified. After desalting, the protein was applied onto 
a DEAE-Sephadex A-50 column, equilibrated in medium B, and the inhi-
bitor was isolated with an NaCl gradient. 
4.4.2 Comparison of the electrophoretic mobility of the RNase 
inhibitor from different organs. 
The inhibitor preparations obtained after DEAE-Sephadex A-50 
chromatography were loaded on top of basic Polyacrylamide gels 
(pH 8.9). The protein patterns of DEAE-Sephadex material after gel 
electrophoresis are shown in fig.7. 
. 
a b c d e f g h 
Fig.7. Analytical Polyacrylamide gel electrophoresis 
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at pH 8.9 of partially purified RNase inhibitor: 
DEAE-Sephadex preparations of (a) rat liver (c) 
sheep adrenal (d) rat thymus (f) rat spleen (g) 
calf liver. For comparison calf eye lens inhibi-
tor has been included (b), (e), (h). Gels run 
simultaneously were tested for RNase inhibitor 
activity. The arrows indicate inhibitor activity. 
From fig.7 it can be concluded that the inhibitor isolated from 
all materials tested, migrates with the same mobility and that in 
all inhibitor preparations the inhibitor activity coincides with 
a protein band. 
Sheep adrenal and rat thymus seem to be especially good starting 
materials for the isolation of RNase inhibitor, but it is difficult 
to get these organs in reasonable quantities. 
4.5. Discussion. 
The isolation of the RNase inhibitor, described above, was used 
as a routine purification method, although the procedure has a number 
of limitations. The ammonium sulphate precipitation step provides 
a convenient method for the concentration of the protein from the 
bulk quantities of eye lens supernatant, however, it does not result 
in a higher specific activity of the inhibitor preparations. After 
chromatography on DEAE-Sephadex A-50 columns only 20% of the origi-
nal RNase inhibitor activity remains.To obtain higher yields after 
DEAE-Sephadex chromatography, 30% glycerol was included in the media 
used, in order to protect the inhibitor from inactivation, as has 
been applied by Lindberg and Skoog (1970), and indeed the activity 
of the inhibitor containing fractions eluted with a sodium chloride 
gradient from the column was increased by about 10-20%. However the 
gain in activity was lost again due to the necessity for extensive 
dialysis to remove the glycerol. 
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Further purification of the RNase inhibitor on Sephadex G-100 columns 
resulted in preparations of a specific activity between 5,000 and 
10,000 units per mg of protein. Occasionally higher specific acti-
vities up to 40,000 units per mg of protein were obtained. Comparing 
our purification method with the isolation method used by Gribnau 
(1970) the yield and specific activity of the purified RNase inhi-
bitor are about the same (compare table IV). 
Higher purification of the inhibitor by specific binding of the in-
hibitor to immobilized alkaline RNAse as described by Gribnau (1970) 
could not be reproducibly achieved by us. This negative result can 
easily be explained. Commercially available immobilized RNase pre-
parations had to be washed in order to remove unbound or dissociated 
alkaline RNase. This washing procedure was never completely sufficient 
and resulted in columns with a very low capacity. This has also been 
observed by others (Gagnon and de Lami rande 1973 and Gribnau et al. 
1970b). To improve the binding capacity of the columns, a spacer was 
applied between the solid matrix and the RNase. This method has been 
used succesfully by others (Cuatrecasas 1972). However, the expected 
improvement was not obtained because as well as the binding of the 
inhibitor, non-specific adsorption of other proteins present in the 
inhibitor preparations was also observed. This non-specific adsorp-
tion has also been reported by Jost et al.(1974), Barry and 0'Carra 
(1973) and Er-el et al. (1972). In order to obtain very highly puri-
fied inhibitor preparations electrophoresis at an alkaline pH was 
introduced as a purification step. After the electrophoretic run 
the inhibitor retained, its activity, at least partially (section 
4.3.2.1.) and extraction of the inhibitor containing gel slices 
revealed a protein preparation free of other proteins as is shown 
in fig.6. Unfortunately all inhibitor activity is lost during ex-
traction and therefore the electrophoretic purification method only 
yields rather pure but inactive inhibitor preparations. 
Comparing the electrophoretic mobility of the RNase inhibitor, iso-
lated from different sources (fig.7), the assumption seems to be 
justified that the inhibitor present in the organs tested might be 
identical. 
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In summary it may be concluded that at this moment there is still 
no procedure available for the isolation of pure, active RNase 
inhibitor in reasonable amounts. Considering the instability of 
the inhibitor activity and the small quantities in which the pro-
tein is present in different organs, finding such a procedure will 
be à difficult accomplishment. In fact the lability of the active 
site of the protein seems to increase concomitantly with the puri-
ty of the protein. Therefore the specific activity of the purified 
inhibitor is not á good measure for the actual purity of the pre-
paration. The electrophoretic appearence of the inhibitor on an 
alkaline Polyacrylamide gel might therefore be a useful tool to 
check the purity of the inhibitor preparations. 
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CHAPTER 5 
FURTHER CHARACTERIZATION OF THE RNase INHIBITOR FROM CALF EYE LENS. 
Some characteristics of the RNase inhibitor were described in 
chapter 2 and further characterization of the inhibitor with pre-
parations of different purity has been carried out. The results 
are presented here. 
5.1. Glycoprotein character of the inhibitor. 
It has been suggested that the RNase inhibitor is a glycoprotein 
(Shortman 1962). A specific staining method for glycoproteins, the 
PAS staining technique according to the method of Zacharias (1969), 
was used to determine the glycoprotein nature of the RNase inhibi-
tor. 
When DEAE purified inhibitor preparations, prepared from calf eye 
lens and calf liver, were applied on top of an alkaline gel (des-
cribed in section 3.3.1), electrophoresed and stained with this PAS 
method there was no indication of any PAS positive protein in the 
region of the inhibitor activity. A number of proteins, present in 
the DEAE preparations, gave positive reactions with the PAS stain-
ing method and these proteins, located in the upper part of the gel, 
were used as positive controls. 
5.2. Isoelectric point of the calf eye lens alkaline RNase 
inhibitor. 
A pH gradient ranging from pH 3 to pH 6, prepared as described 
in section 3.4, was used to determine the isoelectric point of the 
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RNase inhibitor. DEAE-Sephadex purified inhibitor or inhibitor 
purified further on Sephadex G-100, briefly dialysed against distil­
led water, was used for the isofocusing experiment. When the run 
was terminated fractions of about 1.3 ml were collected and tested 
for inhibitor activity, and the pH of each fraction was determined. 
The result is given in fig.8. 
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Fig.8. Isoelectric point determination of the RNase 
inhibitor. RNase inhibitor, purified on Sephadex G-100, 
was isofocused in a gradient ranging from pH 3 to pH 6. 
o-o inhibitor activity (U/ml). 
·-· pH. 
The isoelectric point for the alkaline RNase inhibitor from calf 
eye lens was found to be pH 4.5. This value is in good agreement 
with the isoelectric point of 4.3 obtained for the RNase inhibitor 
isolated from cow liver (Buri 1971). 
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5.3. Molecular weight of the inhibitor. 
The first molecular weight estimate was reported by Priess and 
Zillig (1967), who recovered the inhibitor in the void volume of a 
Sephadex G-75 column, suggesting a value greater than 50,000 dalton. 
Takahashi (1970) suggested a molecular weight of 60,000 dalton after 
chromatography on Sephadex G-100 using the Andrews (1964) procedure. 
Takahashi isolated the inhibitor from pig cerebral cortex, while 
the inhibitor described by Priess and Zillig (1967) was isolated 
from erythrocytes. Gribnau et al. (1970a) using the Andrews (1964) 
method reported a molecular weight of 50,000 dalton for the inhibi­
tor isolated from rat liver. The molecular weight of the inhibitor 
isolated from cow liver was also determined with Sephadex chroma­
tography by Buri (1971). He obtained a molecular weight of 55,000 
dalton. Ortwerth and Byrnes (1972), however, reported a molecular 
weight of 32,000 dalton for the inhibitor isolated from calf eye lens. 
This result could not be confirmed by us. 
The inhibitor preparations, isolated from calf eye lenses, resulted 
in an average molecular weight of 54,500 dalton. The value was ob­
tained as the result of twenty-five experiments carried out on 
Sephacex G-100 columns. The value of 54,500 is in close agreement 
with the value reported for the inhibitor from other sources 
(Gribnau 1970, Buri 1971). 
However, the molecular weight values calculated from electrophoretic 
mobility in the presence of SOS do not support the value calculated 
after Sephadex G-100 chromatography. When alkaline RNase inhibitor 
was isolated in 3 different ways, the patterns obtained on SDS Poly­
acrylamide gels show an identical pattern. 
The 3 inhibitor preparations used were isolated as follows: 
a. extraction of inhibitor from alkaline Polyacrylamide gels 
(chapter 4.3.2.2.). 
b. Sephadex G-100 chromatography. 
с Inhibitor from calf liver purified by affinity chromatography. 
The results are shown in fig.9. 
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1 2 3 
Fig.9. Polyacrylamide gel electrophoresis of RNase inhibi-
tor in the presence of SDS as described in section 3.3 .4. 
The 30,000 dalton regions are indicated by arrows. 
Gel 1: Inhibitor extracted from alkaline gels (4.3.2.2.). 
Gel 2: Inhibitor purified by Sephadex G-100 chromatography 
(top fraction: 30,000 U/mg protein). 
Gel 3: Inhibitor purified by affinity chromatography 
(spec. act. 70,000 U/mg protein). 
Gels 1,2 and 3 were not run simultaneously, so the locali-
zation of the inhibitor bands differs. 
The material extracted from analytical Polyacrylamide gels containing 
the inhibitor activity, yielded 2 protein bands with molecular weights 
of 30,000 and 28,000 dalton on electrophoresis in SDS Polyacrylamide 
gels. This result was confirmed using RNase inhibitor isolated from 
calf liver. The inhibitor fraction isolated after Sephadex G-100 
chromatography and the inhibitor purified by affinity chromatography 
also showed 2 proteins in the 30,000 dalton region. These results 
strongly support the idea that the inhibitor having a molecular weight 
of about 55,000 dalton is composed of two polypeptide chains, each 
having a molecular weight of about 30,000 dalton. 
The two subunits are probably not held together by an S-S bridge, be-
cause when 2-mercaptoethanol was omitted from the sample and from the 
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electrophoresis buffer no difference in the pattern was observed. 
5.4. N-terminal Amino Acid. 
When the inhibitor was extracted from analytical Polyacrylamide 
gels and the isolated protein was subjected to amino acid analysis, 
a high content of acidic amino acids was found (Glu and Asp 27%). 
Attempts to determine the N-terminal amino acid of the inhibitor 
with the aid of 1-dimethylaminonapthalene-5-sulphony1 chloride 
(DNS-C1) according to the methods of Zanetta (1970) and Gros (1969) 
were unsuccesful; therefore it is possible that the N-terminal amino 
acid is blocked. 
5.5. Effect of X-irradiation on the ribonuclease inhibitor level 
in rabbit eye lens. 
The inhibitor activity was determined in lenses in which a 
cataract had been produced with the aid of X-rays. The left lens 
of New Zealand rabbits was irradiated once with about 1800 rad. as 
described by Liem (1974). Approximately three months after irradia-
tion the cataract was mature and both eyes were isolated from the 
rabbit. Both eye lenses were dissolved by homogenization in 0.5 ml 
of 0.1 M Tris-HCl, pH 7.8 to which was added 0.001 M 2-mercaptoetha-
nol and the homogenate was tested for inhibitor activity. The inhibi-
tor activity in the cataractous lens was very low and decreased to 
almost undetectable levels; the normal (right) lens contained consi-
derable more RNase inhibitor (about 10 units per lens). Thus the 
lower inhibitor levels found in senile and galactose cataracts 
(Maione et al.1968, Ortwerth and Byrnes 1971) are also found in 
cataracts induced by irradiation. 
5.6. Specificity of the inhibitor towards a ribosomal ribonuclease. 
The specificity of the RNase inhibitor to different RNases is 
discussed in section 2.4. In recent years a ribosomal RNase has been 
reported associated with rat liver polysomes(Gavard 1972, Kreche-
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tova 1972, Ingebretsen 1972), and with polysomes isolated from 
rat spleen (Willis and Starr 1972). The difference between alkaline 
RNase and the ribosomal RNase was mainly based on a different beha­
viour towards cations and EDTA. But the existence of a ribosomal 
RNase can be demonstrated more easily because there is a difference 
in interaction between alkaline RNase and the ribosomal RNase with 
the alkaline RNase inhibitor as will be shown below. 
5.6.1 Isolation of the ribosomal RNase. 
The ribosomal RNase is prepared as follows: livers from young 
(2-3 months old) male wistar albino rats, starved for 16 h before 
killing, were homogenized in ice-cold 0.05 M Tris-HCl,pH 7.6 buffer 
containing 0.35 M sucrose, 0.25 M KCl and 0.001 M MgClp. After 
centri fugati on at 12,000 g for 20 min, the supernatant was layered 
onto a discontinuous sucrose gradient, consisting of 2 layers of 
10 ml 1.5 M and 10 ml 2.0 M sucrose prepared in the same buffer. 
After centri fugati on for 16 h at 78,000 g the free polysomes were 
suspended in 0.05 M Tris- HCl pH 7.4, 0.005 M MgCl2 and 0.1 M KCl. 
This suspension contained about 10 mg RNA/ml. Solid ammonium chlori­
de was added to the suspension to a final concentration of 0.5 M. 
The suspension was kept for one hour on ice, and was continuously, 
gently agitated. After one hour the polysomes were removed by cen-
trifugation and the remaining supernatant was tested in an assay sys­
tem consisting of 100 μΐ supernatant solution 100 μΐ H2O or inhibi­
tor solution of 1 mg/ml, 200 pi Tris buffer pH 7.8 and 200 yl 1% RNA 
solution. The incubation mixture was further handled as described 
in section 3.6. 
5.6.2 Properties of the ribosomal RNase. 
The effect of monovalent and divalent cations on the behaviour 
of ribonuclease from rat liver was studied by Rahman(1966). The 
three RNases studied by Rahman (1966) have pH optima at pH 5.3 
(RNase I), pH 8.0 (RNase II) and pH 9.5 (RNase III). We studied 
ribosomal RNase and compared its properties with these RNases in 
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spite of different RNA preparations. The pH optimum of the ribosomal 
RNase was 8.0 and on raising the Tris-HCl concentration from 0.067 M 
to 0.3 M (final concentration) in the test system the activity decrea­
sed IQ%. The effect of KCl and NaCl on the ribosomal RNase activity 
was about the same as compared with the two alkaline rat liver 
RNases. A concentration of 0.15 M NaCl caused a 50% loss of RNase 
2+ 
activity. The effect of Mg was also about the same as for the 
„3 
RNases with pH optima at 8.0 and 9.5. A concentration of 10 M 
2+ Mg increased the activity if compared with samples to which no 
2+ 
Mg was added. The same rise in activity was observed with ribo­
somal RNase. The ribosomal RNase activity decreased to undetec-
-1 2+ table levels when 10 M Mg was added; this is in agreement with 
the trend observed with the other two alkaline RNases. The effect 
of EDTA on ribosomal RNase resembles the result obtained for RNase 
-4 III. A sharp decrease in activity was observed between 10 M and 
10" 3 M EDTA. 
Together with these similarities some differences were found when 
-3 
using divalent cations; 5.10 M CaCL· inhibited the ribosomal 
RNase completely, but RNase II and RNase III retained about 50% 
of their activity under these conditions. The same result was found 
with 5 χ ΙΟ"4 M ZnS04. 
In summmary we may conclude that differences in activities between 
alkaline and ribosomal RNases can only be detected in the presence 
of Ca - and Zn ions. 
5.6.3 Effect of the alkaline RNase inhibitor on ribosomal RNase. 
Compared with alkaline RNase from bovine pancreas, ribosomal 
RNase has a different behaviour towards alkaline RNase inhibitor. 
This is demonstrated in table V. 
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Table V. Effect of alkaline RNase inhibitor on ribosomal RNase. 
Reaction mixture in μ!. Absorbance at 260 nm. 
Pancreatic 
\alk. RNase 
-
100 
100 
-
-
н2о 
200 
100 
-
100 
-
Ribosomal 
RNase 
-
-
-
100 
100 
Inhibitor 
solution 
-
-
100 
-
100 
0.020 
0.727 
0.031 
0.173 
0.192 
Effect of the alkaline RNase inhibitor on pancreatic alkaline 
RNase and liver ribosomal RNase. All volumes are given in μΐ and 
200 μΐ RNA (1%) and 200 yl buffer was added to all incubation mix­
tures (section 3.6). Preparation of ribosomal RNase is described 
in 5.6.1 and the inhibitor solution contained 1 mg/ml calf liver 
RNase inhibitor, with a specific activity of 350 U/mg protein. 
The table demonstrates clearly that alkaline RNase inhibitor has 
no inhibiting effect on ribosomal RNase. This ribosomal RNase 
could perhaps play an interesting role in the RNA degradation 
process. 
5.6.4 Possible function of ribosomal RNase. 
The ribosomal bound RNase, which cannot be inhibited by the 
alkaline RNase inhibitor, can perhaps play a role in the degrada­
tion of m-RNA. If this ribosomal RNase has a function in the break­
down of m-RNA, it may be possible that this RNase is absent in 
systems, which have stable m-RNA's e.g. eye lens and reticulocytes. 
When polyribosomes were isolated either from rat liver or rabbit 
reticulocytes or calf eye lenses and washed with 0.15 M NH.C1, the 
results given in table VI were obtained. 
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 Table VI. Presence of ribosomal RNase on polyribosomes isolated from different systems. 
pancreatic 
alk. RNase 
_ 
100 
100 
-
-
н2о 
200 
100 
-
100 
-
Reaction mixtu 
RNase inhibí 
solution 
_ 
-
100 
-
100 
re in 
tor 
wl. 
Ribosomal 
RNase 
_ 
-
-
100 
100 
Absorbance at 260 nm 
Ribosomal 
RNase from 
rat liver 
0.035 
0.732 
0.041 
0.232 
0.242 
Ribosomal 
RNase from 
reticulocytes 
0.035 
0.732 
0.041 
0.065 
0.072 
• 
Ribosomal 
RNase from 
calf eye lens 
0.035 
0.732 
0.041 
0.040 
0.023 
Presence of ribosomal RNase on polyribosomes isolated from rat liver, rabbit reticulocytes 
and calf eye lenses. All volumes are in yl and to all incubation mixtures was added 200 μΐ 1% RNA and 
200 ul buffer pH 7.8. The test conditions and concentrations are described in section 3.5. The RNase 
inhibitor solution contains one mg protein per ml and the spec. act. was 350 U per mg of protein. 
These results show that the ribosomal RNase is absent in polysome 
washings from reticulocytes and calf eye lenses. When polyribosomes 
isolated from thymus tissue or rat spleen were treated with 0.5 M 
NH.C1, the ribosomal RNase was present again in the 80,000 g super-
natant. 
This ribosomal alkaline RNase may play an important role in degra-
dation of m-RNA, because it is absent in systems which have stable 
messenger RNA. 
5.7. Discussion. 
In this chapter we have established that the RNase inhibitor 
from calf eye lens is a protein with an isoelectric point of 4.5. 
In view of the negative PAS-staining the inhibitor is probably not 
a glycoprotein as has been suggested for the inhibitor from rat 
liver by Shortman (1962). Due to the impossibility of dansylating 
the N-terminal amino acids it may be possible that the N-termini 
are blocked. 
On SDS Polyacrylamide gels the most purified inhibitor prepara-
tions contained two protein bands in the 30,000 dalton region. In 
most cases the two protein bands have the same intensity after stain-
ing with Coomassie Brilliant Blue. The combined molecular weight of 
these two chains gives a value similar to that obtained by us for 
the alkaline RNase inhibitor after Sephadex G-100 gel filtration 
(section 4.2.3.3.) and similar to that reported by a number of other 
workers (Gribnau 1970, Buri 1971, Takahashi 1970). The only publi-
cation mentioning a molecular weight below the 55,000 dalton region 
was by Ortwerth and Byrnes (1972). These authors reported a molecu-
lar weight of 32,000 dalton for the alkaline RNase inhibitor from 
calf eye lenses but on repeating their isolation procedure as exactly 
as possible we obtained an average molecular weight of 55,000 dalton. 
Although we found some variation in the molecular weight of the 
various inhibitor preparations the lowest molecular weight ever 
obtained by us was 43,000 dalton. It is possible that they 
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isolated an inhibitor which was dissociated for some unknown reason. 
The ribosomal RNase and its properties have been described by a num-
ber of authors (Gavard and de Lami rande 1972, Ingebretsen et al. 
1972 and Krechetova et al.1972). Although these authors studied the 
effect of added metal ions on the activity of the enzyme, they did 
not verify the possible presence of these ions in the materials 
used. This makes the interpretation of these results difficult. 
We have shown that an easy way to distinguish the ribosomal RNase 
from adhering supernatant alkaline RNase is its behaviour towards 
the alkaline RNase inhibitor. While the alkaline RNase is inhibited 
completely by the RNase inhibitor, the ribosomal RNase is not inac-
tivated by this protein (table V). About the function of the ribo-
somal RNase we can only speculate, but it is tempting to believe 
that it is virtually absent in cells with stable m-RNA's. 
70 
CHAPTER б 
THE RNase-RNase INHIBITOR COMPLEX. 
Up to now most studies have been focussed on ribonuclease 
inhibitor and very little is known of the RNase-RNase inhibitor 
complex and its formation. We have tried to study these problems 
by isolation and purification of the RNase-RNase inhibitor complex. 
The isolated RNase-RNase inhibitor complex was identified on seve­
ral kinds of Polyacrylamide gels and with column chromatography. 
In these experiments the inhibitor activity was detected by en­
hanced ribonuclease activity present after pCMB treatment. pCMB 
destroys the inhibitor activity completely but has no effect on the 
alkaline RNase activity. The enhancement of the RNase activity is a 
measure for the amount of RNase previously present in the complex. 
6.1. Preparation of the RNase-RNase inhibitor complex. 
The RNase-RNase inhibitor complex was prepared by mixing a calf 
eye lens inhibitor preparation with bovine pancreatic alkaline 
RNase. The pH of the buffer used should not be very extreme; not 
above pH 9 and not below pH 4.5. The incubation time can be 
very short but usually the inhibitor was allowed to react at least 
15 min at room temperature. 
A second method to prepare RNase-RNase inhibitor complex is incuba­
tion of alkaline RNase with RNase inhibitor purified on preparative 
alkaline gels. When preparative alkaline gels are loaded with about 
4 mg DEAE-Sephadex purified calf eye lens inhibitor preparations, 
the inhibitor can be determined within 15 min after the run by 
staining and a rapid destaining of a longitudinal slice of the 
preparative gel. The alkaline RNase inhibitor is cut out from 
the unstained part of the gel, minced with a razor blade and mixed 
71 
with a minimal volume of 0.1 M Tris-HCl,pH 7.8 and to this sus­
pension is added an excess of alkaline RNase. After incubation 
at 4 С for et least 15 h the gel particles are removed by cen-
trifugation, extracted again with the same buffer and the combi­
ned extracts are dialysed and lyophilized. 
6.2. Determination of the RNase-RNase inhibitor complex. 
Two methods have been used for the study of the RNase-RNase 
inhibitor complex. One is based on the difference in RNase acti­
vity before and after treatment of pCMB; as already mentioned pCMB 
destroys the inhibitor activity completely but has no influence 
on the alkaline RNase activity. The other method uses radioactive 
labelled alkaline RNase prepared as described in section 3.7. 
6.2.1 Detection of the complex on Polyacrylamide gels. 
A number of Polyacrylamide gel systems have been used to 
determine the RNase-RNase inhibitor complex. 
6.2.1.1 Isofocusing Polyacrylamide gels. 
When DEAE-purified RNase inhibitor is incubated with an 
excess of alkaline RNase, subsequent electrophoresis on isofocus -
ing gels reveals, besides free RNase which is concentrated in the 
region of pH 9.5, RNase activity in the region of pH 6. When such a 
sample of RNase-RNase inhibitor was applied on top of an isofocus -
ing gel, after electrophoresis, a great difference in RNase acti­
vity in the pH region around pH 6.0 was found when the RNase activity 
was measured with and without 10 M pCMB. These results are shown 
in fig.10. 
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Fig.10. Electrophoresis of RNase-RNase inhibitor complex 
in isofocusing gels. 200 pg inhibitor (DEAE-Sephadex 
fraction,spec.act. 650 U/mg protein) was mixed with 5 yg 
alkaline pancreatic RNase and incubated for 15 minutes 
at room temperature. The material was isofocused in a 
Polyacrylamide gel and after terminating the run, the 
gel was cut in 5 mm slices and tested for RNase activity. 
The difference in RNase activity when tested with and 
without 10 M pCMB is a measure of the amount of RNase 
activity blocked by the inhibitor. The test conditions 
are described in section 3.6. 
x-x RNase activity without addition of pCMB 
o-o difference in RNase activity tested with and without 
pCMB 
·-· pH gradient 
The RNase activity detectable in the pH 6 region without addition 
of pCMB to the incubation mixture, is surprising because in that 
pH region no RNase could be demonstrated when RNase alone was 
electrophoresed. Possibly the RNase activity in that part of the 
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gel is complexée! with inactivated RNase inhibitor without dissocia-
tion of the RNase-RNase inhibitor complex. However, RNase activity 
can only be measured in Polyacrylamide gels using a pH gradient 
ranging from pH 10 (top) to pH 3 (bottom). When the pH gradient 
is reversed the protein pattern is disturbed and RNase and inhibi-
tor are not detectable anymore. This phenomenon may be the result 
of precipitation of proteins on top of the gel. 
6.2.1.2. Alkaline Polyacrylamide gels. 
Alkaline RNase, prepared from bovine pancreas was incubated 
with a DEAE-purified inhibitor preparation at room temperature 
and the incubation mixture submitted to electrophoresis on alka-
line Polyacrylamide gels (pH 8.9). 
Gels, run simultaneously, were cut into 0.5 cm pieces and tested 
for RNase activity in the presence and absence of parachloromer-
curibenzoate as described in sections 4. 3.2.1 and 3.6. This method 
revealed considerable differences in alkaline RNase activity, which 
are shown in fig.11. 
Free inhibitor, indicated with an arrow and determined in the same 
run, migrates a little faster in the alkaline gel system than the 
RNase-RNase inhibitor complex. 
Figure 11 shows clearly that when RNase inhibitor is present, RNase 
activity can be determined in the gel. When alkaline RNase alone 
in a quantity about 20,000 times as high as used in the experiment 
depicted in fig.11 was applied on top of an alkaline gel only the 
two or three top slices revealed some RNase activity. 
The electrophoretic properties of the RNase-RNase inhibitor complex 
3 
were also studied with the aid of radioactive labelled RNase.[ H]-and 
35 [ S]-labelled RNases were prepared from rat pancreas as described 
in section 3.7. Labelled RNase, prepared by this method, was still ac-
tive against yeast RNA and no change in the electrophoretic mobility 
in an acidic gel system or in an SDS Polyacrylamide gel, was obser-
3 35 
ved. There was also no difference when [ H]-RNase or [ S]-RNase was 
used. 
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Fig.11. Detection of the RNase-RNase inhibitor complex 
on alkaline Polyacrylamide gels. 220 Units of RNase in-
_3 
hibitor were incubated with 5 χ 10 yg RNase in 40 μΐ 
electrophoresis buffer. After electrophoresis on alka­
line gels the RNase activity was determined with (Δ) 
and without (o) pCMB (section 3.6). The position of 
the inhibitor activity is marked with arrows. 
When calf eye lens inhibitor was incubated with labelled RNase in 
the electrophoresis buffer at room temperature for 15 min and ap­
plied onto the top of an alkaline gel, the same pattern as shown in 
fig. 11 was obtained, after the electrophoretic run. In this case the 
complex that was formed with the labelled alkaline RNase, penetrated 
the gel; if alkaline RNase alone was applied some radioactivity could 
be detected in the top slices of the gel only. 
6.2.1.3 Polyacrylamide electrophoresis at pH 6.0 
To confirm the difference in mobility between RNase and 
its complex with RNase inhibitor, an electrophoretic run was 
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carried out in a 0.05 M phosphate buffer at pH 6.0. In this system 
RNase should move to the cathode, and the mobility of the complex 
should be zero. The mobility of the two proteins on the acidic gels 
was in agreement with these expectations. This is illustrated in 
fig.12. 
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Fi g.12. Electrophoresis of RNase inhibitor complex on 
35 
Polyacrylamide gels at pH 6.0Д S] labelled RNase (pre­
pared as described in section 3.7) was loaded onto the 
top of a Polyacrylamide gel, pH 6.0. The same quantity 
of radioactive RNase was also added to 400 ug DEAE-
Sephadex purified lens inhibitor and applied on top 
of a similar gel. The gels were run simultaneously and 
after the run the gel was cut in 2 mm pieces. The radio­
active material was solubilized with the aid of protosol 
and counted in a toluene based scintillation mix. 
o-o free RNase. 
x-x RNase incubated with inhibitor. 
The arrow indicates migration towards the cathode. 
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6.3. Purification and characterization of the RNase-RNase 
inhibitor complex. 
The DEAE-Sephadex purified calf eye lens inhibitor preparation 
contains, as well as the inhibitor itself, a great number of other 
proteins, but they all possess the property of being adsorbed onto 
a DEAE-Sephadex column under the conditions described in section 
4.2.3.2. Because these proteins are eluted at about 0.25 M NaCl 
in the buffer, there are no problems in adsorbing the proteins 
again onto a DEAE-Sephadex column when the sodium chloride is 
omitted. 
When an inhibitor preparation is incubated with an excess of alka­
line RNase the only protein which can change its properties is 
the alkaline RNase inhibitor. Under the conditions employed, pan­
creatic alkaline RNase is not bound to the DEAE-Sephadex column. 
6.3.1 Isolation of the RNase-RNase inhibitor complex. 
Usually 100 mg DEAE-Sephadex purified alkaline RNase inhibi­
tor was incubated for 15 minutes at room temperature with an excess 
of alkaline RNase and loaded on top of a DEAE-Sephadex A-50 column 
(20 χ 1 cm), equilibrated in medium В (pH 7.0). The column was 
eluted with the equilibration buffer and the fractions were tested 
for RNase activity with and without 10 И pCMB. The results are 
shown in fig. 13. 
-3 
The difference in RNase activity,tested with and without 10 M 
pCMB, disappeared when the DEAE-Sephadex purified inhibitor was 
heated at 60 С for 10 minutes before the alkaline RNase was added. 
When RNase alone was applied and eluted from the column no differ­
ence in RNase activity was found in the presence or absence of pCMB. 
This isolation procedure makes it possible to isolate the RNase-
RNase inhibitor complex in a simple fashion by changing the pro­
perties of the RNase inhibitor by complex formation. 
After elution from the DEAE-Sephadex column the RNase-RNase inhibi­
tor complex was dialysed and lyophilized. 
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Fi g.13. Chromatography on DEAE-Sephadex A-50 of the RNase-
RNase inhibitor complex. 50 mg inhibitor (DEAE-Sephadex 
material, spec. act. 600 U/mg protein) was incubated with 
600 pg RNase, and loaded onto a DEAE-Sephadex column 
(20 χ 1 cm), equilibrated in medium В pH 7.0. After eluti on 
the difference in RNase activity was tested with and with­
out pCMB. The difference in RNase activity is indicated 
by ·-·, the left hand vertical axis indicates the corres­
ponding values. The RNase activity determined in the pre­
sence of pCMB is also shown (o-o). The right hand vertical 
axis refers to these values. 
6.3.2. Characterization of the isolated RNase-RNase inhibitor 
complex. 
The isolated RNase-RNase inhibitor complex was characterized 
in two ways. The first method uses Sephadex G-100 chromatography 
and the second Polyacrylamide gel electrophoresis. 
78 
6.3.2.1 Sephadex G-100 chromatography. 
When the purified RNase-RNase inhibitor complex was loaded 
onto a Sephadex G-100 column, equilibrated in medium С (pH 6.0), 
RNase activity was found in two regions; the 55,000 and 13,500 
dalton region and the RNase activity in the 55,000 region increas­
ed further when pCMB was added to the test system. The same mole­
cular weight for the complex was obtained when RNase inhibitor, 
purified on DEAE-Sephadex, was incubated with alkaline RNase and 
chromatographed on Sephadex G-100. The results are shown in 
fig.14. 
I i • 4 t 
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Fig.14. Gel filtration on Sephadex G-100 of the 
RNase-RNase inhibitor complex. The gel filtration 
was performed on a Sephadex G-100 column (120 χ 2.8 cm) 
equilibrated in medium С and eluti on was performed 
with the same medium.The upper part of the figure 
shows the elution profile of the RNase-RNase inhibitor 
79 
complex prepared by incubation of alkaline RNase 
with an excess of DEAE-purified calf eye lens RNase 
inhibitor. The lower part shows the elution profile 
of the RNase-RNase inhibitor complex, prepared and 
purified as described in section 6 3.1 
o-o RNase activity with addition of pCMB to the test 
system. 
x-x RNase activity without addition of pCMB to the test 
system. 
The elution volumes of the markers used are indicated 
with a letter: V= void volume (dextran blue) B= bovine 
serum albumin (mol. weight 68,000) 0= ovalbumin 
(45,000)С = chymotrypsinogen (25,700) and R= RNase 
(13,700). 
The results,obtained with Sephadex G-100 chromatography, demonstra­
te that the protein preparation, isolated after elution on DEAE-
Sephadex contains, in addition to free alkaline RNase, the RNase-
RNase inhibitor complex. 
6 3.2.2 Polyacrylamide gel electrophoresis at pH 8.9. 
The isolated RNase-RNase inhibitor complex was further charac­
terized by the method described in section 6.2.1.2. The DEAE-Sepha-
dex purified RNase-RNas° inhibitor complex was, after dialysis and 
lyophilization, applied onto the top of an alkaline gel and the 
RNase activity was determined with and without pCMB The results 
are shown in fig. 15. 
As is shown in fig. 15 the mobility of the two RNase-RNase inhibi­
tor complexes is identical and this demonstrates clearly that the 
material not bound to the DEAE-Sephadex column (section 6.3.1), 
contains the RNase-RNase inhibitor complex. 
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Fig.15. Polyacrylamide gel electrophoresis at pH 8.9 of 
the RNase-RNase inhibitor complex. The mobility of the 
complex on alkaline Polyacrylamide gels was compared. 
One gel was loaded with DEAE-Sephadex purified inhibi­
tor incubated with alkaline RNase (·-·) and another gel 
with the complex (o-o) purified as described in section 
6.3.1. The activity curves show the difference in RNase 
activity when tested with and without pCMB as described 
in section 3.6. 
6.3.3. RNase-RNase inhibitor complex on SDS Polyacrylamide gels. 
The behaviour of the RNase-RNase inhibitor complex isolated 
by two different methods and with inhibitor preparations from 
different organs (calf eye lens and calf liver) was studied. 
6.3.3.1. RNase-RNase inhibitor complex prepared with electro-
phoretically purified inhibitor. 
Preparation of the RNase-RNase inhibitor complex with the 
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inhibitor purified by electrophoresis at alkaline pH, is described 
in section 6.1. The sample was prepared for SDS electrophoresis 
as described in section 3.2.4 and applied ontoan SDS Polyacrylamide 
gel. The result is shown in fig.16, gel 2. 
« I 
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Fig.16. SDS electrophoresis of RNase-RNase inhibitor 
complex. Gel 2 shows RNase-RNase inhibitor complex 
prepared with RNase inhibitor purified on alkaline 
Polyacrylamide gels as described in section 6.1. 
Gel 4 shows RNase-RNase inhibitor complex prepared 
from calf eye lens inhibitor and purified on DEAE-
Sephadex as described in section 6.3.1. Gel 6 shows 
RNase-RNase inhibitor complex prepared from calf 
liver RNase inhibitor and purified on DEAE-Sephadex 
as described in section 6.3.1. Gel 1,3 and 5 are 
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reference gels and the markers used were: Bovine 
serum albumin: 68,000 dalton. Ovalbumin: 45,000 
dalton, Chymotrypsinogen A: 25,700 dalton and 
RNase: 13,700 dalton. 
The arrows indicate the tentative RNase-RNase 
inhibitor complexes. 
Next to the tentative RNase-RNase inhibitor complex (indicated with 
an arrow) two inhibitor subunits in the middle of the gel and alka­
line RNase, which was added in excess, are present in the RNase-RNase 
inhibitor preparations. The molecular weight of the tentative RNase-
RNase inhibitor complex was about 45,000 dalton. 
6.3.3.2 RNase-RNase inhibitor complex prepared from partially 
purified calf eye lens inhibitor. 
The DEAE-Sephadex-purified RNase inhibitor isolated from calf eye 
lens was incubated with an excess of alkaline RNase and again passed 
over a DEAE-Sephadex column. The material isolated as described in 
section 6.3.1 showed difference in RNase activity when this was deter­
mined in the presence or absence of pCMB. After dialysis and lyophili-
zation the material was applied onto the top of an SDS Polyacrylamide 
gel. The protein pattern is shown in fig.16 (gel 4). Gel 4 shows four 
protein bands. The protein band with the highest molecular weight 
(about 45,000 dalton), indicated with an arrow, is the supposed RNase-
RNase inhibitor complex. The proteins present in the 20,000 region 
(in the lower half of the gel) are respectively the В and A chain of 
a-crystallin and these bands were also present when the DEAE-Sephadex-
purified inhibitor was rechromatographed on DEAE-Sephadex under the 
conditions used for complex isolation. The protein with the highest 
mobility is alkaline RNase. 
6.3.3.3 RNase-RNase inhibitor complex prepared from calf liver 
inhibitor. 
DEAE-Sephadex-purified RNase inhibitor isolated from calf liver 
was incubated with an excess of alkaline RNase and chromatographed 
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on DEAE-Sephadex, equilibrated in medium В at pH 7.0, as described 
in section 6.3.1 for calf eye lens inhibitor. After dialysis and 
lyophilization the complex was applied onto the top of a Polyacryl­
amide gel prepared in an SDS containing system. The results is shown 
in fig.16 gel 6. The purified RNase-RNase inhibitor complex prepa­
ration yields 2 bands namely the tentative complex indicated with 
an arrow and alkaline RNase. The result of the SDS Polyacrylamide 
gels is that in all cases of complex preparation an new protein is 
present in the 45,000 dalton region. So it seems very likely that 
the new protein, especially when electrophoretically purified inhi­
bitor is used, is the RNase-RNase inhibitor complex. 
6.4 The RNase-RNase inhibitor ratio in the complex. 
In section 4.2.2 it was assumed that alkaline RNase and its 
natural inhibitor form a complex in which RNase and the inhibitor 
are present in a ratio of 1:1. However, the ratio in the complex 
can probably be changed, especially when the quantities of alkaline 
RNase added are increased. That the quantity of alkaline RNase 
which can be bound by the alkaline RNase inhibitor exceeds the 
ratio of 1:1 is demonstrated in table VII. 
Table VII. Effect of different quantities of alkaline RNase on 
the RNase activity in the complex. 
Added quantity of RNase activity (Absorbance at 260 nm) 
RNase. (pg) + pCMB - pCMB 
21 3.87 3.221 
10.5 3.83 2.884 
5.25 3.85 2.974 
0.525 3.370 0.399 
0.053 0.741 0.031 
0.005 0.117 0.035 
390 Units of alkaline RNase inhibitor were incubated in 
the electrophoresis buffer with different quantities of alkaline 
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RNase. After electrophoresis on alkaline Polyacrylamide gels the 
RNase activity present in the RNase-RNase inhibitor complex was 
-3 
determined in the assay system with and without 10 M pCMB as 
described in section 3.6. The table gives the absorbance at 260 nm 
of the acid soluble degradation products of RNA. 
RNase inhibitor (390 Units) was incubated with different quantities 
of alkaline RNase, applied onto the top of an alkaline gel and 
electrophoresed. The RNase-RNase inhibitor complex migrated, under 
the conditions used, half way into the gel as described in section 
6.2.1.2. Gels, run simultaneously, were divided into 5 mn slices 
and tested for RNase activity with and without pCMB. 
390 Units of inhibitor 600 yg of DEAE-Sephadex purified calf eye 
lens inhibitor, can, when the ratio in the complex is 1:1, inhibit 
0.975 \ig alkaline RNase. One would expect that when no pCMB is added 
to the assay system in which the slices are tested for RNase activi-
ty, no RNase activity should be observed. If pCMB is added to the 
assay system the RNase activity, starting with the lowest RNase con-
centration, increase until a constant level is reached. This level 
should be reached when the ratio RNase-RNase inhibitor is unity. 
As shown in table VII the results with pCMB are as expected but the 
RNase activity revealed without the addition of pCMB is unexpectedly 
high when the ratio RNase-RNase inhibitor becomes greater than unity. 
It is impossible that free RNase migrates to this part of the alkali-
ne gel so there must be another explanation. 
An explanation for this surprisingly high RNase activity may be 
that alkaline RNase is associated with the RNase-RNase inhibitor 
complex, but it retains its activity. The association does not 
change the electrophoretic mobility of the complex and so at least 
the greater part of the charge of the RNase molecule is neutra-
lized. A second possibility is that the alkaline RNase inhibitor 
loses its specific property i.e. inhibition of alkaline RNase, 
but the bond between alkaline RNase and its natural inhibitor 
is not broken. The last possibility is not very likely because 
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the RNase activity is much too high for inactivation of the inhibi-
tor. The same association effect was observed with Sephadex G-100 
chromatography. After Sephadex G-100 chromatography no RNase 
activity could be demonstrated when the inhibitor was in excess, 
but when RNase was in excess, RNase activity without any addition 
of pCMB could be detected in two regions, namely in the 13,500 dalton 
and the 55,000 dalton region. The fact that the molecular weights 
of the free inhibitor and RNase-RNase inhibitor complex are about 
the same cannot be explained satisfactorely. 
6.5. Dissociation of RNase-RNase inhibitor complex. 
Up to now very little has been established regarding the dis-
sociation of the RNase-RNase inhibitor complex. We studied the 
influence of acid, urea and pCMB on this complex . The results 
are presented here. 
6.5.1 Effect of acid on RNase-RNase inhibitor complex. 
To study the effect of acid treatment on the RNase-RNase inhibi-
35 tor complex [ S]-labened RNase was incubated at room temperature with 
an excess of calf eye lens RNase inhibitor, partially purified on 
35 DEAE-Sephadex A-50. The possible unbound alkaline [ S]-RNase was 
removed by Polyacrylamide gel electrophoresis at pH 8.9. The com-
plex containing gel fraction was stored overnight either in acidic 
electrophoresis buffer at pH 3.9 as described in section 3.3.5 or 
in a 2% solution of acetic acid. The complex containing gel frac-
tions were applied onto acid!'- Polyacrylamide gels at pH 3.9 and 
following electrophoresis, the radioactivity was determined after 
dividing the gel into 2 mm slices. The radioactive patterns are 
shown in fig.17. 
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Fig.l7. Dissociation of the RNase-RNase inhibitor after 
35 
acid treatment. After isolation of [ S] RNase-RNase in-
hibitor complex from alkaline Polyacrylamide gels, the 
complex was treated with acetic acid. After this incu-
bation with acid, the complex was electrophoresed again 
on acidic polyacryalmide gels, divided into 2 mm slices 
and, following solubilization of the gel slices, the 
radioactivity was determined with a liquid scintillation 
counter, o-o alkaline RNase, x-x RNase-RNase inhibitor 
complex after acetic acid treatment. 
An identical result is obtained when RNase and RNase inhibitor are 
incubated separately in an acidic buffer. No complex formation could 
be observed after 24 h of incubation and the identical radioactive 
pattern shown in fig.17 was produced . This result demonstrates that 
no complex formation occur, when alkaline RNase and alkaline RNase 
inhibitor are incubated in an acidic buffer system. In fact, even 
complete dissociation of the complex could be achieved when the 
RNase-RNase inhibitor complex, purified on alkaline Polyacrylamide, 
was treated with acetic acid (fig.17). 
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6.5.2 Effect of urea on RNase-RNase inhibitor complex. 
In order to study the dissociation of the RNase-RNase inhibitor 
complex further, 130 units of RNase inhibitor were incubated with 
oc 
[ SO labelled RNase. The reaction was allowed to continue for 15 
minutes and following this, different quantities of cyanate-free 
urea were added to the samples. The urea containing samples were 
allowed to stand at room temperature for 90 minutes and were then 
applied onto the top of alkaline Polyacrylamide gels (pH 8.9). 
After electrophoresis the gel was divided into 2 mm slices and the 
radioactivity was determined, after solubilization, with a toluene 
based scintillation solution. The RNase activity, revealed in the 
complex, is shown as the percentage of RNase, determined in the 
complex when no urea was added (fig.18). 
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Fig.18. Effect of urea on the RNase-RNase inhibitor 
complex. Various quantities of urea were added 
to identical samples of RNase-RNase inhibitor 
complex, prepared in alkaline electrophoresis buffer 
and further handled as described in the text. The 
RNase activity in the complex is given as a percen-
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tage of the RNase activity revealed in the complex 
when no urea was added. 
As fig.18 shows, if the concentration of urea is 1.0 M or lower, no 
dissociation occurs; when the concentration exceeds 3.0 M urea the 
RNase-RNase inhibitor complex is completely dissociated. 
6.5.3 Effect of pCMB on RNase-RNase inhibitor complex. 
As has been shown, the RNase-RNase inhibitor complex dissocia-
tes in acidic solutions and in solutions containing 3 M, or higher, 
concentrations of urea. It is also knonw that RNase can be reacti-
vated, after inactivation by RNase inhibitor, by addition of pCMB. 
This SH-reagent destroys the inhibiting activity of the RNase inhi-
bitor and even after complex formation RNase can be fully activated 
by the addition of pCMB. But this reactivation of RNase is not the 
result of dissociation of the complex as is shown in fig.19. 
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Fig.19. Effect of pCMB on the RNase-RNase inhibitor complex. 
89 
JvU 
Free RNase inhibitor and [ S] RNase-RNase inhibitor com­
plex were treated in the electroforesis buffer with 
1.7 χ 10 M pCMB (final concentration) for 2 h at 37° С 
г35 ι 
[ SJ labelled RNase was added to the treated RNase inhi­
bitor and all samples were applied onto the top of an 
alkaline gel. After the electrophoretic run, t: ° gel was 
divided into 2 mm slices and the radioactivity was deter­
mined as described in section 6.2.1.3. 
·-· [ S] RNase-RNase inhibitor complex, not treated. 
oc 
x-x [ Si KNase-KNase i n h i b i t o r complex, treated with pCMB. 
зь 
o-o i n h i b i t o r , treated with pCMB before addit ion of [ S] 
RNase. 
Figure 19 shows that when the inhibitor is pretreated with pCMB, a 
complex with alkaline RNase can still be formed. Also treatment of 
the RNase-RNase inhibitor complex with pCMB does not influence the 
electrophoretic mobility of the complex on alkaline Polyacrylamide 
gels; so it seems obvious that pCMB does not dissociate the RNase-
RNase inhibitor complex. Reactivation of alkaline RNase is probably 
due to an allosteric change in the inhibitor molecule, without 
breaking the bond between RNase and the inhibitor. 
6.6. Discussion. 
So far relatively little attention has been paid to the RNase-
RNase inhibitor complex. We have shown that such a complex can easi­
ly be obtained by DEAE-Sephadex chromatography (section 6.1). It has 
to be admitted that calf lens complex preparations after purification 
on DEAE-SEphadex A-50 columns still contain appreciable amounts of 
a-crystallin. However, the interference with this protein is not 
too serious since the detailed knowledge in our laboratory concer­
ning the localization on Polyacrylamide gels and on various chroma­
tographic columns enables to discriminate between the complex and 
a-crystallin. 
The mobility of the RNase-RNase inhibitor complex in various poly-
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acrylamide gel systems (section 6.2.1.1., 6.2.1.2 and 6.2.1.3) 
suggests that the electrophoretic behaviour of the complex resem-
bles that of the free inhibitor . Besides the similarity in electro-
phoretic behaviour of the free inhibitor and its complex with alka-
line RNase (especially on alkaline Polyacrylamide gels) virtually 
the same molecular weight for the free RNase inhibitor and the RNase-
RNase inhibitor complex is observed upon Sephadex G-100 gel filtra-
tion. Gel filtration of the complex yields an approximate molecular 
weight of 55,000 dalton. One would expect that at least a value of 
about 68,000 dalton since the molecular weights of the KNase inhibi-
tor and RNase are 55,000 dalton and 13,700 dalton, respectively. 
The discrepancy between the expected molecular weight and the esti-
mated value is also observed after electrophoresis on SOS Polyacryl-
amide gels. Instead of the assumed 68,000 dalton a value of 45,000 
dalton is found with this method. It is not very easy to interpret 
these unexpected results. It might well be that in SDS the confor-
mation of the complex has been changed in such a way that the lower 
value is obtained. But even if this is the case we have to explain 
why the inhibitor and the complex both have apparently a similar 
molecular weight as estimated by gel filtration. In our opinion the 
assumption that the inhibitor molecule and the complex have almost 
the same size and shape would overcome this difficulty. One can 
imagine that the inhibitor molecule contains one or more cavities 
in which RNase molecules fit. The shape of this complex might change 
to some extent in SDS, resulting in the lower molecular weight. 
Dissociation of the complex is not necessarily a concomitant event 
if electrostatic forces between inhibitor and RNase play a major 
role in the complex formation. This interpretation seems only to 
be weakened by our observation that dissociation of the complex in 
urea does take place strongly suggesting that also hydrophobic inter-
action is involved in complex formation. Roth and Hurley (1966) also 
proposed that besides electrostatic interaction hydrogen bonds may 
play a part in the RNase-RNase inhibitor interaction.Since the 
sample for SDS electrophoresis is at pH 6.8 while the sample for 
electrophoresis in urea is dissolved in a buffer at pH 8.9, it might 
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well be that the dissociation in the urea media is due to the fact 
that electrostatic forces are no longer operative [the isoelectric 
point of RNase is about pH 8.9).On the other hand our finding of 
2 subumts of the inhibitor could explain the behaviout of the com-
plex on SDS gels if we assume that only one subumt (30,000 dalton) 
would interact with RNase (13,700). However, this assumption does 
not explain the Sephadpx G-100 gel filtration results 
Ou» proposed model of the complex also explains the equal mobility 
of free inhibitor and the RNase-RNase inhibitor complex nn alkaline 
Polyacrylamide gels.Since the inhibitor and its complex have elec-
trophoretir mobilities corresponding to their isoelectric points 
of 4.5 and about 6.0, it is conceivable that the major pa»t of the 
charge originating from RNase is masked in the complex 
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Summary. 
In this thesis the isolation of an alkaline RNase inhibitor and 
its complex formation with alkaline RNase is described. 
Following a review of the literature in the first chapter, in the 
second chapter the properties of the RNase inhibitor which have 
been described until now are discussed. The first step in the 
isolation of the RNase inhibitor from calf eye lens is an ammonium 
sulphate precipitation. Further purification of the labile protein 
is achieved by successive elutions from DEAE-Sephadex and G-100 
Sephadex columns. However, the inhibitor content of the G-100 frac-
tions is still low in the majority of cases. Further purification 
of the RNase inhibitor was not possible with the available chro-
matographic procedures, not even with affinity chromatography. 
On the other hand the RNase inhibitor can be purified using elec-
trophoresis in an alkaline Polyacrylamide gel system. The mobility 
of the RNase inhibitor in this gel system is high due to its iso-
electric point which is pH 4.5. The electrophoretic mobility of 
the RNase inhibitor isolated from a number of other organs and 
species is identical to the mobility of the calf eye lens inhibi-
tor. The molecular weight of the alkaline RNase inhibitor is 55,000 
dal tons when determined by Sephadex G-100 chromatography. The RNase 
inhibitor appears to be built up from two subunits with molecular 
weights of 30,000 daltons each. The electrophoretic properties of 
the RNase-RNase inhibitor complex do not differ greatly from those 
of the RNase inhibitor itself. This complex can be demonstrated 
by the use of a chemical modification (pCMB) which inactivates the 
inhibitor but leaves the alkaline RNase unaffected. Even though 
the electrophoretic properties of the RNase-RNase inhibitor complex 
are in general similar to those of the free RNase inhibitor, the 
charge difference is sufficiently great to permit the isolation 
of the complex from the partially purified inhibitor preparation. 
The complex formation produces a change in the inhibitor properties 
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which is significant enough to prevent binding of this complex 
to the ion exchanger under conditions suitable for the binding 
of the free inhibitor. It appears to be possible that in the 
presence of excess RNase more than one RNase molecule can bind 
to the alkaline RNase inhibitor without affecting the mobility 
of the complex in an alkaline gel system. Dissociation of the 
RNase-RNase inhibitor complex could be achieved by treatment of 
the complex with acid or urea » but not by pCMB. 
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Samenvatting. 
In dit proefschrift wordt de isolatie van een alkalische RNase-rem-
mer en de komplexvorming met het alkalische RNase beschreven. 
Na een literatuuroverzicht te hebben gegeven in het eerste hoofd-
stuk worden in het tweede hoofdstuk de tot nu toe bekende eigen-
schappen van de RNase-remmer behandeld. De isolatie van de RNase-
remmer uit kalfsooglenzen werd begonnen met een ammoniumsulfaat-
precipitatie. Een verdere zuivering van dit labiele eiwit werd 
verkregen met behulp van DEAE-Sephadex-chromatografie en gel fil-
tratie over een Sephadex G-100 kolom. De aktieve G-100 frakties 
bestonden evenwel nog slechts voor een gedeelte uit de RNase-rem-
mer. Verdere opzuivering van de RNase-remmer kon niet bereikt wor-
den met de beschikbare chromatografische procedures, ook niet met 
behulp van affiniteitschromatografie. De RNase-remmer kon wel ge-
zuiverd worden met behulp van elektroforese in een alkalisch poly-
acrylamide-gelsysteem. De mobiliteit van de RNase-remmer in dit gel-
systeeem is groot omdat het isoelektrisch punt van de RNase-remmer 
bij pH 4.5 ligt. De elektroforetische mobiliteit van de RNase-rem-
mer geïsoleerd uit een aantal andere organen en organismen bleek 
dezelfde te zijn als de mobiliteit van de remmer geïsoleerd uit 
kalfsooglens. Het molekuul van de alkalische RNase-remmer was 55.000 
dal tons wanneer het molekuulgewicht bepaald werd met behulp van gel-
filtratie op Sephadex G-100. De RNase-remmer bleek te zijn opgebouwd 
uit twee subeenheden met een molekuulgewicht van ongeveer 30.000 
daltons. De elektroforetische eigenschappen van het RNase-RNase rem-
mer-komplex kwamen nagenoeg overeen met die van de RNase-remmer. 
Dit komplex kon worden aangetoond docr gebruik te maken van een 
verbinding (pCMB) die de remmer inaktiveert maar de aktiviteit van 
het alkalische RNase niet aantast. Hoewel van het RNase-RNase remmer-
komplex de elektroforetische eigenschappen nagenoeg overeen kwamen 
met die van de vrije RNase-remmer waren de ladingsveranderingen 
groot genoeg om op eenvoudige wijze het komplex te kunnen isoleren 
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uit de gedeeltelijk gezuiverde remmer-preparaten. De komplexvorming 
had een dusdanige verandering van de remmereigenschappen tot gevolg 
dat binding van het komplex aan een ionenwisselaar, onder kondities 
waarbij de vrije remmer gebonden wordt, niet meer mogelijk was. De 
binding van meer dan één RNase-molekuul aan de alkalische RNase-rem-
mer,zonder dat de elektroforetische mobiliteit in een alkalisch gel 
systeem merkbaar verandert,lijkt mogelijk. Dissociatie van het RNase-
RNase remmerkomplex kon bereikt worden door behandeling met zuur of 
ureum maar niet door het al eerder genoemde pCMB. 
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STELLINGEN 
I 
De bewering van Bell, dat bij behandeling met neuraminidase van de 
M variant van a,-antiprotease de Ζ variant wordt verkregen, wordt 
niet ondersteund door de experimentele resultaten. 
Bell, O.F. en Carrell, R.W. (1973) Nature, 243, 410. 
II 
Gezien het brede spectrum van proteases dat geremd wordt door de 
hoofdcomponent van de a.-globuline fraktie van serum is het juis­
ter te spreken van a.-anti protease dan van a.-antitrypsine. 
Talamo, R.C. (1971) J.Allergy Clin.Immunol. 48, 240. 
H I 
Bepaling van het protease inhibitor phenotype met behulp van iso-
elektrofocussering tussen pH 3,5 en 6 in Polyacrylamide slab gels 
is in vele opzichten superieur aan de tot nu toe bekende bepalings­
methoden. 
IV 
Het feit dat Pannell na isolatie van α,-antiprotease slechts twee 
banden verkrijgt met behulp van isofocussering tussen pH 4 en 6 
duidt op een verlies van essentiële o^-antiprotease componenten 
tijdens de gevolgde isolatie procedure. 
Pannell, R., Johnson, D. en Travis, J. (1974) 
Biochemistry 13, 5439. 
ν 
Door Lavers wordt onvoldoende aangetoond dat het poly A bevatten­
de RNA, geïsoleerd uit kalfsooglenzen, ook werkelijk messenger 
RNA is. 
Lavers, G.C., Chen, J.H. en Spector A. (1974) 
J.Mol.Biol. 82, 15. 
VI 
De door Corradi η toegepaste analytische technieken bij de karak­
terisering van het semi-synthetisch verkregen (HSE-65) cytochroom 
C, zijn onvoldoende om de inhomogeniteit van het biologisch ak-
tieve produkt aan te tonen. 
Corradin, G. en Harbury, H.A. (1974) B.B.R.C. 61, 1400. 
VII 
Door Chan wordt op onvoldoende wijze aangetoond dat de gevolgde 
isolatieprocedure resulteert in zuiver α,-antiprotease. 
Chan, S.К., Luby, J. en Wu, Y.C. (1973). 
FEBS Letters. 35, 79. 
VIII 
Het verdient aanbeveling om jongeren voor hun twaalfde levensjaar 
te testen op de mogelijkheid van a-,-antiprotease deficiëntie. 
Bij een aanwezige deficiëntie kan gewezen worden op de verhoogde 
kans op luchtwegaandoeningen die mede veroorzaakt worden door 
exogene faktoren. 
IX 
De huidige, snelle waardestijging van de betere nederlandse post-
zegels kan door de ware philatelist slechts betreurd worden. 
X 
Een rijk(s)genoot is meestal niet rijk en soms niet genood. 
Nijmegen, 27 november 1975 W.G.M.v.d.Broek 



